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ABSTRACT
The metastatic process requires the ability of cancer cells to break the basement mem-
brane and migrate through a complex three-dimensional environment. The laboratory 
has recently identified the protein liprin-α1 as an important regulator of integrin me-
diated focal adhesion dynamics and cell motility in non-neuronal cells (Asperti et al., 
2009, Asperti et al., 2010).  Liprins are a family of cytosolic scaffold proteins including 
the liprin-α and liprin-β subfamilies based on sequence similarities (Serra Pagés et al., 
1998). The human genome encodes four liprin-α (liprin-α1-4) and two liprin-β proteins 
(liprin-β1 and liprin-β2). Interestingly, the gene PPFIA1 for liprin-α1 is frequently am-
plified in tumors. Moreover, the levels of expression of the liprin-α1 protein are often 
increased in human breast cancers (Astro et al., 2011). Functional analysis has revealed 
that liprin-α1 is specifically required for migration and invasion in vitro of highly invasi-
ve MDA-MB-231 human breast cancer cells. The analysis of lamellipodia dynamics has 
revealed a decrease of the stability of these protrusions in cells depleted of endogenous 
liprin-α1, which are defective in cell motility. Furthermore, liprin-α1 silencing causes a 
reduction of tumor cell invasion through Matrigel. The examination of the invasive po-
tential has demonstrated that liprin-α1 is important also for the degradation of the extra-
cellular matrix (ECM) (Astro et al., 2011). Starting from these observations, the first aim 
of my project has been to investigate the function of liprin-α1 in vivo. I have generated 
MDA-MB-231-derived cell lines with either stable overexpression or stable depletion of 
liprin-α1, and I have used these cells for injection or transplantation in mice, to determine 
their invasive potential. The characterization of these cell lines in vitro has confirmed that 
liprin-α1 overexpression causes an increase of both cell migration on FN and invasion 
through Matrigel, by promoting the stability of the lamellipodia. On the other hand, li-
prin-α1-depleted cells have reduced ability to both migrate and invade in vitro. However, 
all the cell lines with altered liprin-α1 levels have shown similar proliferation rates and 
viability compared to the control MDA-MB-231 cells. To investigate the involvement of 
liprin-α1 in invasion in vivo, experimental metastasis assays and spontaneous metastasis 
assays were performed. In both assays, the formation of lung metastases by the modified 
and control breast cancer cell lines has been evaluated. The results indicated that liprin-α1 
overexpression did not affect lung colonization. Considering the high invasive ability of 
MDA-MB-231 wild type cells, increase in lung colonization by liprin-α1 overexpression 
may be irrelevant in vivo. On the contrary, injection of liprin-α1-depleted cells resulted 
Abstract
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in the reduction of the formation of lung metastases compared to control cells. This is the 
first evidence that liprin-α1 is not involved in primary tumor growth, while it is important 
for tumor cell invasion. 
Being a scaffold protein, liprin-α1 is unlikely to act alone as a regulator of tumor cell 
invasion. Previous studies have described the interaction between liprin-α1 and liprin-β1 
(Serra-Pages et al., 1998), and have suggested a possible role of  liprin-β2 in migration 
and invasion (von Thun et al., 2012). However, the available data on the functions of li-
prin-β proteins and their relationship with liprin-α1 are not exhaustive. As the second aim 
of my PhD, I have addressed the biochemical interaction of liprin-α1 with either liprin-β1 
or liprin-β2, and I have tried to elucidate the role of the two proteins in cell motility and 
invasion. While liprin-α1 interacts with liprin-β1, it does not interact with liprin-β2. This 
is the first evidence of the different ability of the two liprin-β proteins to interact with 
liprin−α1. The biochemical analysis has shown that the interaction between liprin-α1 and 
liprin-β1 occurs via the C-terminus of liprin-α1, and that two of the three SAM domains 
of liprin-α1 are sufficient to mediate this interaction. 
The study of the subcellular localization has indicated that liprin-β1 colocalizes with 
liprin-α1 at the cell edge, whereas liprin-β2 partially colocalizes with cortactin-positive 
invadopodia. Functional analysis has shown that liprin-β1 silencing did not affect cell 
invasion through matrigel, whereas liprin-β2 silencing led to an increase of cell invasion, 
and enhanced ECM degradation, supporting the hypothesis of the different role of this 
protein in regulating the function of invadopodia with respect to liprin-α1 and liprin-β1. 
Analysis of the involvement of liprin-β1 and liprin-β2 in cell migration underlined the 
different effects of the two proteins. As previously observed for liprin-α1 (Astro et al, 
2011), silencing of liprin-β1 led to a decrease of the speed of the cells in random migra-
tion assays. On the contrary, liprin-β2 silencing did not significantly affect cell motility. 
These data support the hypothesis of a cooperation between liprin-α1 and liprin-β1 in 
regulating cell motility, while they indicate that liprin-β2 does not have a relevant role in 
this process. 
Altogether the work presented in my thesis sustains a key role of liprin-α1 as a positive 
regulator of the invasive apparatus of tumour cells in vivo, and has highlighted for the 
first time first time distinct roles of liprin-β1 and liprin-β2 in tumor cell motility.
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1 INTRODUCTION
1.1 Pathogenesis of Cancer disease
In the 70s, Stehelin and colleagues identified for the first time mutations in a set of regu-
latory genes that bestowed to the cells malignant properties (Stehelin et al 1976). Starting 
from this discovery, it has been proposed the theory of somatic mutation (SMT). This the-
ory sustains that cancer is a disease that begins at cellular levels with a somatic mutation 
(M.Bizzarri et al., 2008). In the years, great efforts have been done to identified the gene-
tic alterations that trigger carcinogenesis. Nowadays, tumorigenesis is widely considered 
a multistep process consisting in the progressive acquisition of molecular alterations that 
drive the transformation of a normal cell to a malignant cell. The acquisition of several al-
terations leads, in the time, to a considerable heterogeneity among cancers (Hanahan and 
Weinberg, 2000). Despite more than 100 types of cancers have been described, in the last 
decade scientists have identified a small number of circuits that control cell homeostasis 
and that are altered in almost the totality of cancers. Genetic alterations in these circuits 
confer to the cells specific capabilities, identified as the six hallmarks of cancer (Fig1.1) 
(Hanahan and Weinberg, 2000). These hallmarks have been described as: self sufficiency 
in growth signals, insensitivity to anti-growth signals, evading apoptosis ability, sustai-
ned angiogenesis, limitless replicative potential, tissue invasion and metastasis. None of 
these hallmarks can independently lead to a malignant trasformation of a normal cell, but 
the combination among them allows cells to survive, proliferate and disseminate. After a 
decade, several studies have identified  two new capabilities that are common to cancer 
cells and that have been added to the list of the initial six hallmarks: the metabolic repro-
gramming and the ability to evading immune response (Fig 1.2) (Hanahan and Weinberg, 
2011). Moreover, two new enabling characteristics have been considered driving forces 
of trasformation: genomic instability and tumor-promoting inflammation. In particular, it 
is evident that inflammation occurs in the early stages of tumorigenesis and can contribute 
to the acquisition of the hallmarks by supplying proliferative, survival and proangiogenic 
factors. Althought the acquisition of the hallmarks is a concept widely accepted, recently, 
new theories and evidence about the bases of the cancer disease have added complexity 
to the scenario. An alternative view about the origin of the cancer disease sustains that 
cancer is a tissue-based disease rather than a somatic mutation-based disease. In contrast 
with the somatic mutation theory, it has been proposed the theory of the tissue organi-
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zation field (TOFT) that identifies the reciprocal interaction between the stroma and the 
parenchymal cell as the target of alteration rather than the DNA. According to this theory, 
the chronical alterated interactions between the stroma and the parenchima of a morpho-
genetic field result in carcinogenesis. This theory suggests also that the acquisition of the 
hallmarks is a consequence of this altered link (Laconi 2007; Sonnenschien and Soto, 
2013). Another emerging concept is the reversibility of cancer trasformation. It has been 
proposed that the re-establishment of a physiologic interaction between cancer cells and 
microenvironment may reverse the neoplastic phenotype. In support of this hypothesis 
many studies indicated that “cancer can be epigenetically be reprogrammed into normal 
cell types” (Li et al., 2003). Supporting this idea, it has been shown that a neoplastic cell 
introduced into a blastocyst or implanted in a normal microenvironment, contributes to 
develop a normally structured organ (Lee at al., 2005; Cucina et al., 2006). 
Although the SM and TOF theories are still under debate, it has become widely accepted 
that cancer is not only a mass of uncontrolled proliferating cells but a complex tissue 
composed by different types of cells interacting and influencing each other and with the 
microenvironmnet (Hanahan and Weinberg 2011). In particular, the role of the stroma as 
a promoter of cellular proliferation, genomic instability and cell motility is today object 
of increasing interest and attention (Laconi 2007).
Fig 1.1 The hallmarks of cancer. Scheme of the six hallmarks of cancer proposed by D. Ha-
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1.1.1	 Breast	cancer:	complexity	and	classification
Breast cancer is the most frequently diagnosed cancer among women ranking as second 
(10.9% of all cancers) and fifth as causes of death for cancer worldwide (Ferlay et al., 
2010). Breast cancer is not a unique and simple disease, but it is an heterogeneous and 
complex pathology that includes different histopathological subtypes with genetic and 
genomic differences (Ellsworth et al., 2009). Traditional classification have regarded in 
particular the tissue components originating the tumor. Based on this criterion, breast 
cancers have been divided into two main groups: carcinomas and sarcomas. Sarcomas 
originate from the connective tissue of the mammary gland and are less frequent whereas 
carcinomas originate from the epithelial component of the organ (cells from the lobules or 
the ducts). The malignat lesion originating from the ducts is the ductal carcinoma in situ 
Fig 1.2 Emerging hallmarks and enabling characteristic: the two new proposed hallmarks of 
cancer: the capability of modifying cellular metabolism and to evade immunological destruction. 
The first supports neoplastic proliferation whereas the second allow overcoming the immuno-
logical response, in particular by T and B lymphocytes, macrophages, and natural killer cells.. 
Additionally, two consequential characteristics of neoplasia facilitate acquisition of both core and 
emerging hallmarks. Genomic instability and thus mutability endow cancer cells with genetic al-
terations that drive tumor progression. Inflammation by innate immune cells can support multiple 
hallmark capabilities, thereby manifesting tumor-promoting consequences of inflammatory re-
sponses. Adapted from “The hallmarks of cancer: The next generation”, Cell,  2011.
Introduction
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(DCIS), that is the most common breast cancer, including the 80% of all breast cancer. 
This carcinoma can become invasive and develop an infiltrating ductal carcinoma (ICD). 
(Fig 1.2) This lesion presents cells that infiltrate the breast connective tissue, lymphatic 
vessels, intercostal vein and can interest also the vertebral plexus. The dissemination 
leads to a colonization of distant organs in particular lymph nodes, bones, lungs and ner-
vous system (Vargo-Gogola and Rosen, 2007).
Tumor subtypes have been classified based on tumor size, lymph node involvement, hi-
stopathological grade, patient’s age and the histological evaluation of the expression of 
ormons receptor (oestrogen receptor ER, progesteron receptor PR) and epidermal growth 
factor receptor  HER-2/ERBB2 (Yersal et al., 2014). However, recent studies have focu-
sed on the gene expression profile of breast cancer ductal carcinoma in order to provide a 
new classification of the different subtypes based on gene expression patterns (Eroles et 
al., 2012) (Fig 1.3). Perou and colleagues have identified two main classes of tumors de-
scribed as ER-positive and ER-negative cancers (Perou et al., 2000). ER-positive tumors 
are characterized by a high expression of the gene specific of breast luminal cells such 
as ER-responsive genes and luminal cytokeratins (CK) but they do not express HER-2 at 
high levels. They constitute the group of the ER-positive luminal-like tumors. Other stu-
dies have identified subclasses of luminal cancers that have been divided in luminal A and 
Figure 1.3 Schematic illustrating various breast cancer subtypes. The blue and pink rectan-
gles group the subtypes based on the expression of ER/PR, positive in the blue (Luminal A and 
Luminal B) and negative (HER2+ and basal-like) in the pink. The central grey rectangle (with 
black outline) indicates the presence of HER2 amplification in Luminal B and HER2+ subtypes. 
Adapted from R. Sandhu et al., Labmedicine 2010.
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luminal B (Sørlie et al., 2001). The ER-negative tumors are further divided into three su-
classes: basal-like, HER-2 positive and normal-like tumors (Fig 1.3) (Yersal et al., 2014).
Luminal A tumors: they are the most common subtypes of cancers representing the 50-
60 % of all breast cancers. These cancers often present low histological grade and low 
proliferation rate (low expression of Ki67), so having a good prognosis and low rate of 
relapse. Relapse can frequently occur in bone (Kennecke et al., 2010). They are ER- and 
PR-positive and HER2-negative. Luminal A cancers are characterized by the expression 
of luminal epithelial cytokeratines 8 (CK8) and 18 (CK18) and other luminal markers 
such as hepatocyte nuclear factor 3 alpha (FOXA1), X-box binding protein1 (XBP1), 
GATA-binding protein 3 (GATA-3), B cell lymphoma 2 (BCL2), erb3 and erb4.
Luminal B tumors: these tumors constitute the 15-20% of breast cancers, they are also 
ER-positive but are more aggressive than the luminal A ones, presenting both higher 
proliferation rate and rate of relapse. In fact, they express higher levels of growth factor 
receptors such as fibroblast growth factor receptor 1 (FGFR1) and HER1, high levels 
of PI-3K, Src and proliferation-related gene such as cyclin E (CCNE1) and Ki67. Since 
there is not a clear distinction between luminal A and luminal B cancers, the evaluation 
of the levels of  Ki67 has been proposed to be useful to discriminate the two subtypes of 
tumors. The overall survival of luminal B breast cancers is worse than the luminal A ones 
being similar to the basal-like and HER-2 positive cancers.
HER-2 positive: the HER-2 subtypes of cancer includes the 15-20% of breast cancer 
subtypes. These cancers are characterized by the high expression levels of HER-2 gene 
and genes correlated to the HER-2 pathway, and low expression of ER. They are more ag-
gressive because of their higher rate of proliferation in comparison to the luminal cancers, 
higher histological grade and a higher rate of p53 mutations (Tsutsui et al., 2003). These 
cancers commonly give rise metastasis in the brain and visceral organs.
Basal-like tumors: this subtype represents the 8-37% of all breast cancers. They are also 
indicated as triple-negative cancers. However, the terms triple negative and basal-like 
are not completely synonimous. Triple-negative tumors lack the expression of ER, PR 
and HER-2 genes and constitute a subclass of basal-like cancers even though the term 
triple negative  is more used in clinical settings. Basal-like cancers have altered expres-
sion levels of gene promoting cell proliferation, survival, migration and invasion. Ba-
sal-like cancers show a de-regulation of some signaling  pathways such as MAPK, PI-3K, 
Akt, NF-kB and beta-catenin. Several myoepithelial markers have been identified for 
basal-like tumors, such as CK5, CK14, CK17 and laminin. It has been also reported that 
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basal-like tumors overexpress P-cadherin, fascin, caveolins-1 and 2 and EGFR. Finally 
they frequently harbor mutation in tumor protein 53 (TP53) gene and present inactivation 
of retinoblastoma (Rb) pathway (Hetiz et al., 2009). 
Basal-like subtype is often correlated with mutation in BCRA1 gene, constituting the 
75% of the BCRA1 gene-related cancers.
Normal-breast like: they represent the 5-10% of all breast cancers. This subclass is poorly 
characterized and these tumors are often grouped with fibroadenoma and normal breast. 
Since they are negative for ER, PR and HER-2, sometimes they are classified as triple 
negative cancers, even thought they are not basal-like carcinomas because they lack the 
expression of CK5 and EGFR. They have an intermediate prognosis between luminal and 
basal-like cancers. Although molecular profiling has provided many information about 
gene expression of particular subtypes of breast cancers, some critics have been raised in 
particular about the validation of the new data and their clinical utility. The identification 
of some subclasses such as luminal A and B is not complitely resolved and the difference 
between triple-negative and basal-like is disputed, yet. However, molecular characteriza-
tion has contributed mainly in the modification of treatment protocol related to ER, PR, 
HER-2 and Ki67 status of breast cancer.
From the clinical point of view, ER-positive cancers are considered the more treatable 
ones since they can respond to endocrine therapies. HER-2 positive tumors can be trea-
ted with anti-ERBB2 therapies while triple negative cancers are not responsive to these 
treatment and can receive the classical chemiotherapy. However, the main cause of death 
in breast cancer patients is the giving rise of long-term metastases. Because of this, the 
study of the mechanisms regulating the formation of metastasis constitutes a central issue 
to be clarified.
1.2 From tumor to metastasis: theories on metastatization
Metastasis derives from the evolution of a specific cancer cell sub-population whose 
expansion is promoted mainly by genomic instability and heterogeneity of tumor cells 
(Chiang et al., 2008). Metastasis formation is a multisteps process that can be synthetized 
in: loss of cellular adhesion, increased motility and invasiveness, entry and survival the 
circulation, exit into a new tissue and its colonization. The entire process is very ineffi-
cient: 10 000 cells can be shed in the circulation every day but only the 0.01%  can survive 
and give rise to metastases (Chambers et al., 2002). Tumor cells die during the metastatic 
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process mainly because of the hemodynamic forces of blood circulation and the induction 
of anoikis due to lack of cell-cell and cell-matrix adhesions (Lorusso and Ruegg, 2012). 
The basic events of metastatic process, such as the enhanced cell invasion and the entry 
in circulation system are common to different types of tumor, while others such as colo-
nization of specific organs are peculiar for types of tumor and types of target organs. Two 
theories have been proposed to describe the metastatic dissemination process: the linear 
and the parallel theory (Fig 1.4). According to the linear theory, cells in the primary tumor 
acquire progressively genetic modifications and as the tumor growth, a subpopulation of 
Fig. 1. 4 Linear and parallel models of metastasis. In the linear model of metastasis genetic 
modifications progressively accumulate in cancer cells of the primary tumor, and a more aggres-
sive subpopulation is selected. Cells acquiring metastatic capacities are more effective in colo-
nizing distant organs. In the parallel model of metastasis, cancer cells disseminate early during 
tumor progression, at a stage when the primary lesion is small or possibly even pre-malignant. 
In breast cancer both models are supported by clinical and experimental evidences. Metastatic 
cells can disseminate through lymphatic vessels and lymph nodes first or directly through the 
blood stream. Cancer cells recirculating from metastases to primary tumors might contribute to 
bad prognostic signatures. P, primary tumor; M, metastasis. Adapted from Lorusso and Ruegg, 
Seminars in cancer biology, 2012.
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more-aggressive cells is selected. Because of this, it has been thought that dissemination 
occurs when the primary tumor has grown considerably. Furthermore, metastasis-driving 
mutations should be detected in metastatic foci and only rarely found in primary tumor 
(Chaffer and Weinberg, 2011). On the other hand, experimental observations of the breast 
cancer tumorigenesis have shown that dissemination occurs also during the early stages 
of tumorigenesis and also at pre-malignant stages. From these evidence it has been pro-
posed the theory of the parallel metastatic process. 
This theory sustains that dissemination is a process concomitant and independent from 
the primary tumor growth (Klein et al., 2009). Moreover, this theory hypothesizes that 
Fig. 1.5 Major mechanisms for breast cancer invasion. Three main mechanisms have been 
identified that mediate breast cancer cell invasion: EMT, collective invasion and macrophage- 
tumor cell interaction. (a) EMT mediates acquisition of mesenchymal phenotype and motility (b) 
Breast tumor cells can migrate through a collective migration. Two cellular population have been 
identified as leader for collective invasion: stromal fibroblast and a subpopulation of cancer cel-
ls. Stromal fibroblast can enhance collective invasion by path clearing and matrix remodeling, 
whereas cancer cells can promote collective invasion through E-cadherin. (c) Macrophages can 
promote cancer cell invasion to blood vessels and mediate extravasation by eithr the macropha-
ge-tumor cell feedback loop mechanis or  the macrophage-tumor cell direct  interaction mechani-
sm. Adapted from Cheung K.J and Edwald A.J. Curr Opin. Cell Biol., 2014.
Introduction
— 17 —
Analysis of the role of liprin proteins in breast cancer cell invasion
metastatic cancer cells may recirculate from metastases to primary tumors, thus contribu-
ting to the onset of drug-resistance of the primary tumor and to a bad prognostic signatu-
re. This process is called reseeding of metastatic cells (Lorusso and Ruegg, 2012).
1.2.1 Early events in metastasis formation
At the bases of metastasis formation there is the ability of cancer cells to detach from the 
primary tumor and migrate through the extracellular matrix invading surrounding tissues. 
The invasiveness of cancer cells can occur mainly by three mechanisms: epithelial-me-
senchymal transition (EMT) that drives individual cell migration, collective invasion and 
macrophage-tumor cell feed-back loop (Fig 1.5) (Cheung and Ewald, 2014).
1.2.1.1 EMT in breast cancer
Initially, to detach from the primary tumor, cells need to break the cell-cell interactions, 
to remodel cell-matrix adhesion sites and follow a stimulus through the extracellular ma-
trix.  In this way, non-motile epithelial cells acquire a non-polarized, motile and invasive 
mesenchymal phenotype. This phenomenon is temporary and reversibile and it is known 
as epithelial-mesenchymal transition (EMT) (Thiery et al., 2006). EMT also occurs in 
non-pathological conditions such as embryonic development. Similarly, in cancer-as-
sociated EMT, molecular pathways typical of embryonic development are re-activated 
(Polyak et al., 2009). EMT can be induced by cellular intrinsic signal such as genetic 
mutations, or external stimuli such as growth factor signaling, (TGFb, HGF, EGF, IGF) 
(Zavadil et al., 2005), tumor-stroma interaction and hypoxia (Foroni et al., 2012). As 
mentioned, the first characteristic of EMT is the involvement of developmental transcrip-
tion factors such as Snail1 and 2, Slug, ZEB1, ZEB2, Twist, Goosecoid, FOXC1, FOXC2 
and E47 (Moody et al.,  2005; Foroni et al., 2012). Moreover other pathways such as Wnt, 
Notch and integrin signals can regulate EMT. (Fig rev foroni) Moreover, emerging evi-
dence underlines the role of microRNAs in inducing EMT-trascription factors and their 
regulation (Zhang et al., 2014). For example it has been demonstrated that Twist induces 
the expression of miR-10b. This microRNA targets and represses the expression of a 
homeobox gene relieving trascriptional inhibition of RhoC, a pro-metastatic Rho family 
GTPase. On the other hand, it has been shown that several other miRNAs have a metasta-
sis suppressor effect (Fig 1.6) (Wang and Wang, 2011). A second characteristic of EMT, 
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is the loss of the E-cadherin expression. Loss of E-cadherin promotes actin-cytoskeleton 
rearrangement and changes in cell polarity promoting cell motility. Associated to the loss 
of E-cadherin it has been also observed a high expression of N-cadherin and vimentin in 
tumor circulating cells (Roussos et al., 2010). Another foundamental feature of EMT is its 
reversibility. In fact, upon the arrival in a new environment, cancer cells undergo mesen-
chymal-epithelial transition (MET), that restores the epithelial phenotype and allows cell 
proliferation and organization to give rise metastases. The role of hypoxia in EMT seems 
to be the support of long-lasting inflammation, caused by an increase of production of 
oxygen-reactive species which in turn activate HIF-1alpha and NF-kB signalling.
1.2.1.2 Individual tumor cell migration
Once loss of cell-cell junction has occurs, tumor cells can migrate and invade surrounding 
tissue individually, by adopting mesenchymal/elongated or amoeboid/rounded phenotype 
(Friedl and Wolf, 2010). The amoeboid/rounded migration occurs when low adhesion 
forces or high actomyosin contractility are involved in the cell. The amoeboid migra-
tion is characterized by the formation of Rac-dependent filopodia and small adhesion 
sites. Amoeboid movement can be alterantively induced by Rho-mediated blebbing of the 
membrane  without the formation of defined adhesion sites (Friedl and Alexander, 2011). 
Fig 1.6 Signaling events during epithelial to mesenchymal transition. Adapted from C. Foro-
ni et al., Cancer Treat. Rev. 2012.
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An important characteristic of amoeboid migration is the lack of  ECM degradation be-
cause cells migrate by adapting their shape to the tissue gaps and trails. Differently, me-
senchymal migration occurs when cells develop prominent cytoskeletal protrusions and a 
great number of adhesion sites with clusters of integrins. In this case, proteases assemble 
at the cell membrane generating microtrack in the ECM allowing cell to penetrate the 
matrix. Different levels of stiffness of the matrix can influence the way of migration by 
promoting either an elongated or a rounded phenotype (Friedl and Wolf, 2009). Indeed, 
elongated or mesenchymal migration occurs when cells invade a highly rigid  ECM. On 
the other hand, migration in a 3D environment that generates low tension force, leads 
cells to the acquisition of a rounded morphology. However, cells that migrate individually 
can switch from an elongated/mesenchymal migration to a rounded/amoeboid migration 
based on the 3D environment and the activation of different pathways inside the cell. 
In fact, the switch is mainly regulated by the balance between the activity of Rac and 
Rho GTPases. In particular, a decrease in Rac activity and a concomitant activation of 
Rho-mediate actomyosin contractility can induce a change from mesenchymal to amo-
eboid migration. The Rac/Rho balance can be regulated by different factors such as the 
therapeutic inhibition of metalloproteases (MMPs), the inhibition of chemokine-media-
ted Rac activation, the activation of Rho by inhibition of its GAP p190RhoGAP, or the 
engagement of indirect Rho activators like EphA2 (Gérard et al., 2007; Parri et al., 2009).
1.2.1.3 Macrophage-tumor cell interaction
In a physiological condition, for example during wound healing, macrophages can coordi-
nate tissue repair by inducing cell migration, matrix remodelling and angiogenesis (Cous-
sens and Werb, 2002). Clinical and experimental evidence has shown that tumor cells 
can recruit a specific population of macrophages, named tumor-associated macrophages 
(TAMs) that are able to facilitate tumor progression and metastasis formation. TAMs can 
promote tumor cell invasion through different mechanisms. It has been demonstrated that 
malignant cells can create a microenvironment that activates the macrophage function as 
in the physiological context by secreting chemoactractant molecules. Tumor-associated 
macrophages, in turn, secrete growth factors and other molecules supporting different 
processes that occur during tumor progression: chronic inflammation, matrix remodel-
ling, tumor cell invasion, intravasation, angiogenesis and colonization of distant organs 
(Condeelis and Pollard, 2006). In particular, macrophages can promote invasion through 
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their ability to remodel extracellular matrix and to secrete growth and angiogenic factors 
(Condeelis and Pollard, 2006). For example, TAMs promote tumor cell extravasation 
and survival by producing vascular endothelium growth factor (Qian et al., 2009).The 
bidirectional paracrine signaling between macrophages and tumor cells is called macor-
phage-tumor cell feedback loop. Moreover, TAMs support tumor cell survival through 
the activation of  the PI3K-Akt pathway. In fact, Cheng and colleagues showed that the 
integrin- a4 expressed on the surface of metastasis-associated macrophages binds vascu-
lar cell adhesion molecule-1 (VCAM1), which is highly expressed by metastatic cells in 
the lung. This interaction leads to VCAM1 clustering, which, in turn, activates PI3K-A-
kt, providing survival signals in tumor cells (Cheng et al., 2011). Moreover, a recent 
study has reported that a direct contact between macrophages and the tumor can induce 
RhoA-dependent formation of invadopodia in cancer cells (Roh-Johnson M et al, 2013).
1.2.1.4 Collective invasion
Several studies have shown that E-cadherin expression varies significantly among histo-
logical breast cancer subtypes. For example, only10% of the ductal carcinoma presents 
the loss of E-cadherin (Gould-Rothberg et al., 2006). On the other hand E-cadherin is 
lost in the majority of lobular carcinomas. Since the ductal carcinoma is the most com-
mon breast tumor, while lobular carcinomas represent only the 10% of all the mammary 
carcinomas, it is reasonable to suggest that the majority of mammary tumors express 
E-cadherin.  It has been also demonstrated that expression of E-cadherin induces tumor 
cells to migrate in a collective manner. In this direction, imaging studies demonstrate 
that collective invasion occurs in several solid tumors and many mechanisms have been 
proposed to explain this process (Nguyen-Ngoc et al., 2012). One mechanism that drives 
collective invasion is the presence of a cellular population that acts as leader for tumor 
cells. Two populations of cells have been identified as leaders of collective invasion: stro-
mal fibroblasts and a subpopulation of breast cancer cells. Stromal fibroblasts are efficient 
in ECM remodelling and it has been demonstrated that they can create micro-tracks that 
drive cancer cells through the ECM. Interestingly, it has been observed that the ECM re-
modelling is regulated by Rho in fibroblasts, while tumor cells migration is under the con-
trol of Cdc42 pathway. Furthermore, the block of Rho signaling in fibroblasts can inhibit 
cancer cells invasion indicating that the targeting of the leaders is sufficient to impair the 
entire metastatic process (Gaggioli et al., 2007). Recently it has been proposed that fibro-
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blast can also support collective invasion of breast cancer cells in a subtype-dependent 
mechanism. Indeed, it has been shown that fibroblasts can lead invasion in basal subtypes 
but not in luminal cell lines. As mentioned, also breast cancer cells can promote collective 
invasion. Multiple studies indicate that within a tumor, cells with high migratory capabili-
ty can act as leaders of collective invasion. For example, cells overexpressing MT1-MMP 
can create micro-tracks facilitating the migration of adiacent cells. A recent study has 
identified a specialized subpopulation of breast cancer cells that is able to trigger collecti-
ve invasion (Cheung et al., 2013). Cheung and colleagues have observed that invasive 
leader cells express basal epithelial genes such as  E-cadherin,  cytokeratin-14 (K14) and 
the transcription factor p63.  Leader cells interact with the follower cells via E-cadherin 
and do not undergo EMT. The expression of K14 has been described as a marker for the 
identification of the major population of leading cells. Consistently, knockdown of K14 
blocks collective invasion in both 3D culture and in vivo. Althought the presence of a 
population of leader cells has been demostrated in different types of cancer even if the 
mechanisms that gives rise this population are not well understood. Probably, alterations 
in ECM composition and changing in signals from microenvironment, both gained and 
lost, may facilitate the emergence of an leader invasive cell subpopulation (Cheung and 
Ewald, 2014).
1.2.2 Late events in metastasis formation: extravasation and tissue colonization
Tumor circulating cells need to cross the vessel walls to colonize distant organs. In this 
step the permeability of the endothelium is fundamental. In some organs, as for liver and 
bone marrow, microvessels have high permeability, allowing tumor cells to easily extra-
vasate. In other cases, as for the brain, blood brain barrier constitutes a wall not freely 
penetrable (Lorusso and Ruegg, 2012). After breaking the endothelial wall, tumor cells 
need to adapt to a new environment. Recently, several molecules have been identified 
that mediate tumor cells homing and colonization (Gupta and Massague, 2006; Fidler 
et al., 2003). For example, overexpression of selectin ligands on tumoral cell surface 
allows cancer cells to bind platelets and leukocytes, enhancing survival in the circula-
tion. Another example is constituted by the amplified expression of CXCR4 and CCR7 
receptor and ligands that allows breast cancer cells to arrest and migrate into a secondary 
organ. (Lorusso and Ruegg, 2012). The localization of metastasis does not occur random-
ly but is influenced by the expression of specific genes that confer a particular tropism 
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and by the features of the target organ. These two aspects may explain why cells deriving 
from different types of cancer can colonize the same target organ. Recently, the genes 
that mediate the metastatization of breast cancer cells to the lung, bone and brain have 
been identified (Minn et al., 2009). In fact, microarray-based comparison of the parental 
cell lines to organotropic metastasis has identified 43 genes overexpressed and 59 gene 
downregulated in bone metastasis induced by injection of triple negative breast cancer 
cell line MDA-MB-231 in mice. Genes such as MMP1, MMP2, LOX, CXCL12 have 
been shown to favour lung colonization by breast cancer cell, the expression of COX2 
has been associated with brain metastasis and the expression of Src, NF-kB and VCAM1 
has been observed in bone metastatic cells (Kang et al., 2003). After homing, metastatic 
cells can quickly produce a detectable metastasis. More frequently, the manifestation of 
a secondary lesion occurs after several years. This is indicated as a phenomenon called 
“metastatic dormancy”. This observation suggests that metastatic cells have a low rate 
of proliferation and are not able to give rise to a secondary tumor at the moment of the 
colonization. This ability is acquired with time, probably through the addition of new ge-
netic and epigenetic alterations and in response to the signals from the new environment 
(Lorusso and Ruegg, 2008). However, there is a great variability in the rise of metastases 
by different types of cancer cells. The mechanisms that regulate the kinetic of this process 
are not well understood and their identification representes an important aim to try to pre-
vent long-term cancer progression.
1.3 Dissecting cell motility: Molecular mechanisms of cell migration
Cell motility is a fundamental requisite of cancer cells to give rise to metastasis at distant 
organs. Motility involves dynamic cytoskeletal modifications, cell-matrix interaction, 
proteolysis, actin-myosin contractions and focal adhesion turn-over. These processes are 
spatially and temporally coordinated  (Friedl and Wolf 2003). The migratory cycle starts 
in a cell that senses and responds to a stimulus activating actin polymerization and the ex-
tension of actin-driven protrusions (filopodia and lamellipodia). At the edge of the protru-
sion new adhesive site are generated and provide the traction force required to move the 
body cell forward. At the back of the cell, disassembly of focal adhesions and cell-surface 
detachment occur, thus allowing retraction of the cell rear and the translocation of the cell 
in the direction of the migration (Mattila and Lappalainen et al., 2008).
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1.3.1 Actin cytoskeleton 
The initial step of the migration cycle is the extension of a protrusion, driven by the dyna-
mic assembly of actin filaments. Actin filaments grow below the plasma membrane and 
their fast polymerization produces the physical forces required for membrane extension. 
Actin filaments are characterized by an intrinsic polarity: they have a plus “barbed” fast-
growing end and a minus “pointed” slow-growing end (Pellegrin and Mellor, 2007). This 
asymmetry allows barbed ends to drive membrane protrusion (Ridley et al., 2003). Three 
mechanisms have been described for the generation of barbed ends: de novo nucleation 
by Arp2/3 complex and formins, severing of pre-existing actin filaments by cofilin, and 
uncapping of barbed ends on pre-existing filaments (Zigmond et al., 2004). In a cell, actin 
filaments are organized in networks that form different types of protrusions: lamellipodia, 
filopodia and podosomes (or invadopodia). Lamellipodia are flat, sheet-like membrane 
protrusions that drive migration through the attachment to the substrate, and generating 
the force to pull the cell body forward (Yamaguchi et al., 2006). Differently, filopodia 
are finger-like membrane extensions consisting of parallel bundles of actin filaments. 
Filopodia are considered to act as sensors that detect the local environment. Podosomes 
are actin-rich-structures generated by cells that physiologically cross the ECM, such as 
macrophages, and are required to remodell the ECM. Also cancer cells produce structu-
res similar to podosomes in order to remodel the ECM and to allow cells to invade the 
surrounding tissues (Jiang et al., 2009). These structures are called invadopodia which 
are ventral protrusions composed by actin and actin regulatory proteins, such as cor-
tactin, adhesion molecules, signal proteins and proteases. Actin can also organize with 
non-muscle myosin in complex and long structures called stress fibers. These structures 
provide the contractile force for cell movement. They can be divided into ventral stress 
fibers, dorsal stress fibers and arcs (Small et al., 1998). In particular, ventral stress fibers 
are linked on both ends to integrin-rich focal adhesions. Moreover, in motile cells ven-
tral stress fibers are oriented parallel to the axis of locomotion thus providing the con-
tractile force for tail retraction and disassembly of focal adhesions (Cramer et al., 1997). 
The organization and remodeling of the actin cytoskeleton is driven by a complex set of 
actin binding proteins (ABPs) (Pollard & Borisy, 2003). They include monomer-binding 
proteins (profilin), depolimerizing proteins (ADF/cofilin), nucleating proteins (Arp2/3, 
WASP, WAVE), barbed ends capping proteins (gelsolin), pointed ends capping proteins 
(tropomodulin), inhibitors of barbed end capping (DRFs, Ena/Vasp), F-actin stabilizing 
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and crosslinking proteins (fascin,  alpha-actinin) and F-actin anchoring proteins (cor-
tactin, vinculin, spectrin). Furthermore, GTPases of the Rho family Rho Rac and Cdc42, 
play a central  role in the regulation of the actin cytoskeleton and therefore in controlling 
cell migration.
1.3.2 The family of Rho GTPases
Rho GTPases are small proteins belonging to the Ras superfamily. They control ac-
to-myosin cytoskeleton and cell adhesion (Wennenberg et al., 2005). The mammalian 
Rho GTPases comprise thirteen isoforms of Rho (Rho1-4 and Rho6-7, RhoA-E RhoG, 
Rho H), three isoforms of Rac (1 -3), Cdc42, and TC10 (Yoshimi et al.,  2001). Small 
GTPases cycle between an active GTP-bound state and an inactive GDP-bound state (Fig 
1.7). This cycle is regulated by guanine nucleotide exchange factors (GEFs) that activate 
GTPases, and GTPases activating proteins (GAPs) that inactivate Rho GTPases. About 
80 GEF proteins have been identified in mammals. They present a Dbl homology domain 
(DH) important for GTPases activation, and a pleckstrin homology domain (PH) that is 
Figure 1.7 The Rho GTPase cycle. RhoGTPases act as molecular switches, cycling between 
two conformational states:GTP-bound active state and a GDP-bound inactive state. In the active 
state these GTPases bind to and activate downstream effectors to generate a biological respon-
se, until GTP hydrolysis switches the protein to the inactive state. The two classes of regulators 
that facilitate the switching on and off of Rho GTPases are the GEFs and the GAPs, respectively. 
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important for their localization at the plasma membrane. The DH domain can bind the 
switch region of Rho GTPases and modify its conformation driving the release of GDP. 
Following that, GTP can bind the GTPase, activating it. The Rho GAP family consists of 
about 65 proteins. GAP proteins act by enhancing the intrinsic hydrolysis of GTP bound 
to Rho GTPases and by stabilizing their GDP-bound conformation (Rossman et al., 
2005). In the cytoplasm, inactive Rho GTPases are complexed with guanosine nucleotide 
dissociation inhibitor (GDI). GDI binds Rho-GTPases through an immunoglobulin-like 
domain at the C-terminal region, and keep the GTPases in a GDP-bound form. The re-
lease of the GDP-bound GTPase from GDI occurs by a still unknown mechanism. Once 
GDI has released the GTPase, a GEF protein converts it in the GTP-bound form that can 
interact with downstream effectors. Rho, Rac and Cdc42 proteins localize in the cytosol 
and can reversible translocate to the plasma membrane (Yoshimi et al., 2001). Rho GTPa-
ses are involved in several cellular processes such as gene expression, cell adhesion, 
migration, cytokinesis, cell cycle progression, transformation and neuronal development 
(Etienne-Manneville & Hall, 2002). However, their main function is to regulate the as-
sembly and organization of the actin cytoskeleton (Hall et al., 1996). In particular, Rho 
proteins regulate the formation of stress fiber and focal adhesion, while Rac and Cdc42 
regulate the formation of lamellipodia and filopodia, respectively. The effects of Rho 
GTPases on the actin cytoskeleton occur through the action of downstream effectors. One 
of the identified Rho effectors is the serine/threonine kinase ROCK. This protein acts by 
interacting with many downstream targets such as the myosin binding subunit of myosin 
light chain phosphatase, myosin light chain, ERM, cofilin and mDia (Amano et al., 1996; 
Kimura et al., 1996; Maekawa, et al., 1999). It has been reported that ROCK and mDia 
cooperate to regulate the organization of actin cytoskeleton (Nakano et al., 1999). Howe-
ver, ROCK phosphorylates LIM kinase, which in turn activates cofilin that severs actin 
filaments (Maekawa et al., 1999). 
1.3.3 Role of Integrins in  cell-ECM interaction 
Integrins are a family of transmembrane receptors that mediate cell-ECM and cell-cell 
interaction. These proteins are involved in several cellular processes such as embryonic 
development, tumor cell growth and metastasis, apoptosis, hemostasis and response of 
the cells to mechanical stress (E.A. et al., 1995). Integrins are heterodimeric proteins 
each composed by one  a- and one b-subunit (Fig 1.8). Nineteen different a- and eight 
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b-subunits  have been identified originating about 25 combinations. Moreover, the genes 
encoding both  a and  b subunits undergo alternative splicing, thus adding complexity 
to the possible combinations generated (Hynes et al., 1992). The extracellular region of 
integrins can bind many components of the cellular matrix such as fibronectin, collagen, 
vitronectin. Each integrin binds a specific ECM protein, even if a single ECM protein can 
be bound by more than one integrin. Some integrins can also bind soluble ligands such as 
fibrinogen or molecules on adjacent cells, such as the adhesion molecule ICAM, leading 
to homo- or heterotypic aggregation (Cadelwood, 2007). The short cytoplasmic domain 
of integrins does not have intrinsic enzimatic activity but aggregates cytoplasmatic pro-
teins, both cystoskeletal and catalytic proteins, giving rise to large protein complexes and 
transmitting outside signals inside the cell (outside-in signaling). On the other hand, the 
interaction with intracellular ligands can induce a conformational change of the extracel-
lular portion of integrins. In this way integrins can regule their affinity for extracellular 
Figure 1.8 The structure of integrins Integrin transmembrane receptors are composed by an α 
and a β chain. They are the structural link between actin cytoskeleton with the ECM, but also the 
functional link for signal transduction. From Pearson Education, 2009.
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ligands (inside-out signaling) (Calderwood 2004). Cytoskeleton-associated proteins that 
interact with integrins are for example talin, vinculin, paxillin and kindlin, while one of 
the most important catalytic protein associated with the integrins is the focal adhesion 
kinase (FAK). In order to transmit the signals in the bidirectional way, integrin receptors 
can switch from a bent-inactive state in which the ligand binding site is close to the in-
sertion of the transmembrane domain, to an extended-active state in which integrins bind 
their ligands. The binding to an extracellular ligand seems to stabilize the active con-
formation of the protein (Pinon and Wehrle-Haller et al., 2010). Ligand-binding causes 
integrins activation and clustering at the cell membrane. Integrin clustering leads to the 
formation of focal adhesions, proteins assemblies that connect the actin-cytoskeleton to 
the ECM (Clark and Brugge, 1995). Moreover, integrin activation can trigger intracel-
lular signals such as protein phosphorylation, tyrosine kinase phosphorylation, activa-
tion of small-GTPases like Rho, variation in the concentration of intracellular calcium, 
changes in the production of phospholipids, regulation of intracellular pH and regulation 
of programme cell death (Harburger and Cadelwood, 2009). Moreover, integrins media-
te the cross talk between different cellular pathways., The focal adhesion kinase FAK, 
following its activation by the b-subunit of integrin, seems to play a central role in this 
process. For example, FAK can interact with both the adaptor protein Crk and PI3K. Crk 
mediates integrin-mediated-Ras-signaling, while PI3K interacts with FAK after stimula-
tion by platelet-derived growth factor. This results in a coordination of proliferation with 
actin cytoskeleton rearrangement (Ridley and Hall et al., 1994).
1.3.3.1	 Integrin	trafficking	in	cell	migration
Integrins are internalized from the cell surface by both clathrin-dependent and clathrin-in-
dependent mechanisms. Integrins are recruited to clathrin-coated structures through the 
interaction between a conserved motif (NXXY motif) localized on the cytoplasmic be-
ta-subunit and the adaptor protein AP2. In addition, it has been recently demonstrated 
that integrins recruitment for clathrin-mediated endocytosis occurs also through the inte-
raction between a different integrin motif (NPXY) with other two adaptor proteins: DAB2 
and Numb (Calderwood et al., 2003). On the other hand, integrins can be internalized in 
a clathrin-independent manner either through RAB21 by a cholesterol-sensitive caveolar 
mechanism (Pellinen et al., 2008), or through a direct interaction between the cytoplasma-
tic domain of b1 integrin and PKCa (Ng et al., 1999). After the internalization, integrins 
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are transported to the early endosomes, and then they are either sent to late endosomes and 
lysosomes for the degradation, or can be recycled to the plasma membrane. The recycling 
can occur either through Rab4-mediated mechanism or a mechanism involving Rab11 and 
Arf6 proteins. This process is regulated by several kinases and GTPases such as Rac pro-
Fig 1.9 Structure of a focal adhesion: A Transmembrane integrins that localize at focal adhe-
sion bind both ECM and a complex of cytoskeletal proteins includining alpha-actinin, vinculin, 
talin, paxillin and tensin that in turn bind actin filaments. B Signaling molecules that interact with 
FAK. FAK associates with the kinase Src, Csk, the adapter protein Crk and Grb2, the GEF Sos 
and C3G. A model for integrin signaling suggests that integrin clustering induces the phosphoryla-
tion of FAK Tyr 397. Once activated, FAK binds Src that in turn induce Ras activation at focal 
adhesion through Grb2-Sos complex Adapted from E. Clark and S. Brugge, Science, 1995.
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tein (Caswell and Norman, 2008). The integrin traffic can influence cell migration through 
different mechanisms: by altering the recycling of growth factor receptors such as EGFR 
and VEGFR, and by regulating the actin polymerization and cell contractility through 
the Rho GTPases signaling (Caswell et al., 2009). In particular, Rho GTPases are closely 
linked to the endosomal transport. In fact, once inactivated, Rac protein recruited to the 
endosomal compartment. Endosomal membrane contains the Rac-GEF TIAM, that can 
re-activate Rac leading to its delivery to the plasma membrane. This allows the enhance-
ment of actin polymerization that supports the extension of membrane protrusion for cell 
migration. Moreover, it has been demonstrated that different integrins can activate specific 
Rho-GTPases to regulate cell motility. For example, avb3 activates Rac supporting the 
formation of lamellipodia, in this way promoting directed migration. On the other hand, 
the presence of integrin a5b1 promotes RhoA-dependent phosphorylation of cofilin, whi-
ch causes the collapse of lamellipodia and increases random migration (Caswell, 2009).
1.3.4 The adhesion to ECM: focal adhesions assembly and disassembly
As mentioned, focal adhesions (FAs), or focal contacts, are adhesive sites that may be linked 
to actin-stress fibers, and contain actin binding proteins and adhesion molecules such as 
integrins. FAs have an elongated streak-like structure that are considered the mature form of 
integrin-mediated adhesive sites (Gardel et al, 2010). Other adhesive structures localized at 
the leading edge are the focal complexes, that represent the immature form of FAs (Nobes & 
Hall, 1995), and fibrillar adhesions, adhesive sites responsable of FN fibrillogenesis (Webb 
et al, 2003). The function of FAs is to stabilize the membrane protrusion and establish a 
structural and signaling link between the extracellular matrix and the actin cytoskeleton (Fig 
1.9A) (Chan et al., 2010). Once actomyosin contraction has moved forward the cell, FAs 
disassembly allows further movement. The assembly of FAs occurs after the extension of 
a new membrane protrusion in order to stabilize cell-matrix conctact. As the assembly, the 
disassembly of focal adhesions occurs at the cell edge, at the basis of lamellipodia, to allow 
the formation of new protrusions and the cell movement. The molecular mechanisms that 
regulate the assembly and disassembly of FAs are not well understood yet (Vicente-Manza-
nares et al, 2005). However, it is clear that Rho GTPases have a central role in these proces-
ses. Indeed, Rac and Cdc42 regulate the formation of nascent adhesions at the front, while 
Rho controls the assembly of mature focal adhesions and myosin-induced contractility at the 
cell rear. Rho proteins are in turn regulated by adhesion-related proteins like FAK, tyrosi-
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Fig. 1.10  Model for lamellipodium formation. 1: Unstimulated cells have non-polarized cell 
morphology in which molecular machinery for barbed end formation including cofilin is inactive. 
2: Chemoattractant stimulation induces local activation of cofilin at the leading edge, which leads 
to severing of pre-existing actin filaments and formation of free barbed ends from which new 
actin filaments are assembled. This initiates membrane protrusions and sets the direction of cell 
migration. 3: Arp2/3 complex and WAVEs associate with newly formed actin filaments and induce 
formation of further barbed ends and the branched actin network. Subsequently, the branched 
actin filaments are stabilized by cortactin. This strengthens the protrusive force of lamellipodia 
and leads to cell movement. Adapted from H. Yamaguchi and J. Condeelis, Biochim Biophys 
Acta, 2007.
ne kynases (Src), tyrosine phosphatases, and multiprotein complexes of G protein-coupled 
receptor kinase interactors (GITs). In particular, integrin-mediated adhesion induces the au-
tophosphorylaiton of FAK in tyrosine 397. This residue is bound by the SH2 domain of 
Src kinase, which in turn can phosphorylate other residues of FAK. The FAK-Src complex 
activates the axis paxillin-GIT1- b-PIX-Rac1 by enhancing membrane protrusion, and inhi-
bits cell contractility facilitating cell spreading  (Huveneers & Danen, 2009). Morover, the 
activated FAK-Src complex can promote Ras activation at focal adhesion through Grb2-Sos 
complex (Fig 1.9B) (Clark and Brugge, 1995).  Focal adhesions disassembly is promoted by 
endocytosis of integrins in a microtubule (MT) dependent process (Ezratty et al., 2009), and 
by degradation by calpains of essential FA components such as FAK and talin (Chan et al., 
2010). During cell migration, the formation of new adhesive sites stabilizes the membrane 
protrusions (Le Clainche & Carlier, 2008). When the cells move forward some of the focal 
complexes at the leading edge mature into FAs that are linked to the stress fibers, while FAs 
disassemble at the cell rear allowing the movement (Kaverina et al, 1998).
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1.3.5 Lamellipodia formation: the driving force of migration
Lamellipodia drive migration through the attachment to the substrate and generating the 
force to pull the cell body forward (Yamaguchi et al., 2006). Formation of lamellipodia is 
regulated by PLC-PIP2-cofilin pathway and by GTPases proteins of the Rho family with 
the WAVE-ARP2/3 complex (Fig 1.10). Cofilin is a small protein of 19kDa that binds 
both monomeric actin and actin-filaments. Its main role is to severe actin filaments at the 
leading edge of a migrating cell, thus increasing the number of barbed ends, which in turn 
may result in the extension of a lamellipodia. This process is regulated by PLC and PI3K 
pathways that promote cofilin inactivation through its phosphorylation. (Yonwzawa et al., 
1990). Either Rho through its effector ROCK, or Rac through PAK can also inactivate 
cofilin inducing its phosphorylation by the LIM kinase (LIMK) (Toshima et al., 2001). 
It has been observed that the precise balance between cofilin activation and inactivation 
by LIMK phosphorilation is crucial for tumor cell migration. Futhermore, several studies 
indicate that spatially and temporally localized activity of cofilin is determinant in chemo-
taxis sensing during invasion (Mouneimne et al., 2004). The ARP2/3 complex localizes 
at lamellipodia to regulate it. ARP2/3 complex is activated by Cdc42 through WASP (Wi-
skott-Aldrich syndrome protein family proteins) or by Rac via WAVE. Once activated, the 
complex ARP2/3 binds an actin filament and iniziates the extension of a new filament. In 
mammalian cells, five WASP-related proteins have been identified: WASP, neural WASP 
and WAVEs 1-3. It has been reported that WAVE2 has a specific role in the formation of 
lamellipodia while WAVE 1 stabilizes the protrusion (Yamaguchi et al., 2007). 
1.3.5.1 Lamellipodia regulation: interplay between different GTPases
Several  studies indicated that a fine balance between the signal of RhoA and Rac1 can 
regulate cell migration through the control of lamellipodia generation. Rac1 levels regu-
late the persistence of migration by influencing the number of peripheral lamellae and 
associated membrane protrusions. High activity of Rac1 promotes the extension of mul-
tiple lamellipodia, enhancing random migration with respect to directed migration that 
is usually mediated by a single stable protrusion. On the other hand, a reduction in Rac1 
activity favours directed migration using axial lamellipodia (Pankov et al., 2005). This 
occurs because moderate or low activity of Rac1 results in the suppression of the ex-
tension of new protrusions, thus favouring the presence of a single lamellipodium that 
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promotes the persistence of migration in one direction. Once activated, Rac traslocates 
at the leading edge of the cells where it interacts indirectly with WAVE to stimulate Ar-
p2/3-mediated actin polymerization, producing lamellar extension and forward cell mo-
vement (Pollard et al., 2000). The loss of directionality also occurs when RhoA activity 
exceeds Rac activity. This impairs the stability of lamellipodia driving the collapse of 
the protrusion (Caswell at al., 2009). The key concept, is that tight changes in Rac1 and 
RhoA activity finely regulates random versus directed migration through the control of 
the number of lamellapodia generated at the cell periphery.
1.3.6 The degradation of ECM in cancer cell: invadopodia 
Invadopodia and podosomes are ventral actin-rich protrusions originally indentified in 
v-src-trasformed fibroblasts (David-Pfeuty and Singer,1980). Initially, both the terms 
have been used for to the same actin-rich invasive structures in the same cells. Nowadays, 
the term podosome is used to indicate these structures in normal cells that are able to re-
model the ECM such as macrophages and osteoclasts and in Src-trasformed cells. Diffe-
rently, the term of invadopodia is used for structures that mediate pericellular proteolysis 
of ECM formed in cancer cells and promote tumor cells invasion and metastasis (Murphy 
and  Courtneidge, 2011; Artym et al., 2013). Invadopodia are structures that have a width 
between 0.5 and 2  mm and a length of about 2 mm. They are composed by an actin-rich 
core colocalizing with several proteins. These structures have peculiar morphological fe-
atures and a specific spatial localization that allow to distinguish them from filopodia and 
lamellipodia. Specifically, invadopodia can be identified by the colocalization between 
ventral actin puncta with focal degradation of the ECM. The proteins involved in invado-
podia structure and function can be grouped in four functional classes: proteins of motili-
ty machine, adhesion proteins, signalling proteins and proteases.  The first group includes 
regulators of F-actin polymerization and branching such as Arp2/3, N-WASP, Cdc42, 
Nck, cofilin, capping proteins dynamin and cortactin. The second group includes inte-
grins that mediate the interaction of invadopodia with the ECM. In the third group there 
are the signalling proteins regulating the actin cytoskeleton, and membrane remodelling 
such as Rho GTPases and kinases, while the fourth group comprises metalloproteases 
such as MMP14, MMP2, MMP9 and the urokinase-type plasminogen activator (uPA)/
uPa receptor proteolytic system (Artym et al., 2013; Gimona et al., 2008). Key regulators 
of invadopodia formation have been identified: the N-WASP-Arp2/3-cortactin complex, 
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Tyr kinase substrate with four SH3 domains (TKS4), Tyr kinase substrate with five SH3 
domains (TKS5), the Tyr kinase SRC and the transmembrane membrane type 1 matrix 
metalloprotease (MT1-MMP) (Clark and Weaver, 2008). Also phoshatases play a central 
role in the regulation of invadopodia. The most important phosphatases identified are the 
5’ inositol phosphatase synaptojanin and the 3’ inositol phosphatase and tumor suppressor 
phosphatase PTEN (Murphy and Courtneidge, 2011). The main function of invadopodia 
is the degradation of ECM in order to allow cell migration through tissues, in particular 
during collective invasion. Recently it has been demonstrated that invadopodia can act 
also as mechanosensors (Albigez-Rizo et al., 2009). In fact, the formation of invadopodia 
seems to be promoted by a decrease in local cellular contractility (Burgstaller and Gimo-
na, 2004). For example the assembly of invadopodia occurs mainly at the ventral surface 
of cancer cells, where traction forces are weaker than at the periphery. 
1.3.7 Mechanisms of invadopodia formation
Several studies indicate that the process of invadopodia formation includes four steps (Fig 
1.11) (Artym et al., 2013). The first step is the formation of the core structure associated 
with actin puncta. This is induced in response to a great number of factors, which can be 
grouped in four main classes: growth factors (EGF, TGF-b, PDGF, HGF), oncogenic tran-
sformation, EMT induction  and hypoxia (Beaty et al., 2014).  It has been suggested that 
these factors may converge in the activation of the Rho GTPase Cdc42. This has been sup-
ported by the observation that Src, a key player in the invadopodia formation, phosphoryla-
tes and activates GEFs for Cdc42 such as Vav1. Therefore, it has been hypothesized that 
the axis EGFR-Src-GEF-Cdc42 may be the major actor in the invadopodia initiation (Be-
aty et al., 2013). Active Cdc42 induces the activation of cofilin-N-WASp-Arp2/3 complex, 
which in turn promotes actin assembly (Artym et al., 2013). Concomitant with this, cor-
tactin accumulates at the ventral cell membrane adherent to matrix. Few seconds after that, 
also the adaptor protein Tks5 is recruited to the core and binds the PIP2 phosphoinositide 
in order to anchor the structure to the plasma membrane (Sharma et al.,  2013). In the sta-
ge 2, it is formed a structure called adhesion ring that stabilizes the nascent invadopodia 
favouring the recruitment of  b1integrins and other proteins such as the formin mDia that 
recruits microtubules to enhance vesicle transport to the invadopodia (Wickströme and 
Fässler, 2011). The role of integrins seems to be foundamental for invadopodia maturation 
since they can interact with the kinase Arg and the integrin-link kinase (ILK) (Branch et 
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al., 2012). Arg phosphorylates cortactin further promoting cofilin-Arp2/3-dependent actin 
polymerization, whereas ILK recruits the scaffold protein IQGAP that in turn induces the 
transport of MT1-MMP to the invadosome. The recruitment of MT1-MMP/MP14 costi-
tutes the third stage of the invadopodia formation (Hoshino et al., 2013). At these step of 
invadopodia formation it occurs also the elongation of actin filaments through the action 
of cofilin. This is mediated by talin. Talin is a focal adhesion protein that is recruited to 
Fig 1.11 Model of invadopodia formation. (1) initiation: Growth factors (GF) interact with their 
receptor leading actin polimerization and invadopodia initiation. Signals from different pathways 
converge  on N-WASP that activates Arp2/3 complex inducing actin polymerization. (2,3) During 
adhesion ring formation proteins such as integrins and ILK are recruited to the nascent invado-
podia. The vesicle capture is mediated by molecules such as IQGAP, mDia, ILK. (4) at the stage 
four ECM degradation occurs. Moreover, proteinase activity may promote feedback signaling to 
enhance the formation of new invadopodia. Adapted from D. Hoshino et al., J. Cell Sci. 2013.
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invadopodia by binding to the actin filament. Talin interact with the ERM family protein 
moesin. Moesin contributes to changes of the intracellular pH disrupting inhibitory in-
teractions between cortactin and cofilin. This allows active cofilin to severe F-actin thus 
generating new actin barbed ends, for extension of the invadopodium (Beaty et al., 2014). 
At stage four, the matrix degradation occurs. Several studies indicate that, at this sta-
ge, mature invadopodia contain microtubules and intermediate filaments. Their recruit-
ment promotes further elongation of the protrusion and the arrival of metalloproteases for 
ECM degradation. The number of invadopodia increases progressively at this stage due to 
the action of MT1-MMP (Artym et al., 2013). This metalloprotease can directly degrade 
ECM, but can also potentiate invadosome initiation by releasing growth factors through 
the proteolysis of their precursors. This occurs through different mechanisms.  MT1-MMP 
cleaves MMP2 that disrups the inhibitory complex of vascular edthelial growth factor 
(VEGF) releasing the VEGF and triggering invasion (Dean et al., 2007). Again, MT1-
MMP  cleaves the TGF-b binding protein LAP determining the release of TGF-b (Mu et 
al., 2002). In addition, MT1-MMP cleaves HB-EGF, which releases an EGF-like domain. 
This peptide strongly stimulates EGFR thus amplifying the invadosome assembly process.
1.3.8 The main actors of invadopodia formation: cortactin and MT1-MMP
Cortactin is an actin-binding protein and is one of the major substrate of Scr kinase. Cor-
tactin is composed by different domains. Four are of particular interest: the N-terminal 
acidic (NTA), a tandem repeats domain, the C-terminal proline rich domain, and a Src-ho-
mology 3 (SH3) domain (Weaver et al., 2008). The N-terminal domain is the binding 
site for the Arp2/3 complex and actin filaments. Through this domain cortactin regulates 
branching of F-actin mediated by Arp2/3 complex (Weaver et al., 2001). The C-terminus 
proline rich domain has regulatory functions. It contains serine/threonine and tyrosine si-
tes of phosphrylation, that are target of several kinases modulating cortactin function. The 
SH3 domain can bind signaling proteins such as N-WASP and WIP (Weaver, et al., 2008). 
Cortactin has different functions: it  stabilizes the newly formed actin filaments network 
(Weaver et al., 2001), regulates the persistence of a protrusion, and promotes the forma-
tion of new adhesions site at the cell edge (Bryce et al., 2005). Moreover, cortactin plays 
a central role in invadopodia formation. Two mechanisms have been proposed to explain 
this function. First, cortactin may promote directly the actin assembly at invadopodial 
puncta. This hypothesis is supported by the observation that in Src-transformed cells, 
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cortactin silencing leads to a reduction of the number of invadopodia pucta (Arthym et 
al., 2013). Second, cortactin may influence invadopodia formation through its interaction 
with proteins N-WASP, WIP and Src kinase. Cortactin binds these proteins via its C-ter-
minal domain. It has been observed that mutations in this region that prevent the binding 
affect invadopodia number and function (Webb et al., 2007).
MT1-MMP (or MMP14) protein belongs to the family of metalloprotease (MMP) that in 
humans includes 25 members (Poincluox et al., 2009). MMP are multifunctional zinc-de-
pendent endopeptidases that can degrade a variety of ECM component such as collagen I, 
II and III, fibronectin. As the other metalloproteases, MT1-MMP is produced as a zymogen 
and it is cleaved in the Golgi giving rise the mature enzyme. The mature protein is anchored 
to the plasma membrane. MT1-MMP has a conserved structure and is composed by a signal 
peptide, a propeptide, and an extracellular catalytic domain (Poincluox et al., 2009). MT1-
MMP is involved in the activation of MMP2 and MMP13, and in the regulation of cell mi-
gration through the proteolytic modification of CD44, the  av integrin and transglutamina-
se. Together with cortactin, MT1-MMP is required for the assembly of invadopodia. It has 
been demonstrated that its overexpression in cancer cells promotes migration, invasion and 
metastasis formation both in vitro and in vivo (Itoh et al., 2004). In particular, MT1-MMP 
mediates mesenchymal migration through the degradation of the collagen. Matrix degrada-
tion is also enhanced by the clustering of MT1-MMP with  b1-integrin at sites of interaction 
between integrin and collagen fibers (Wolf et al., 2003). MT1-MMP can be regulated at dif-
ferent levels: gene transcription, intracellular trafficking and proteolytic activation. The in-
tracellular trafficking is finely regulated both by clathrin-mediated and caveolar endocyto-
sis, while the transport of MT1-MMP at invadopodia is regulated by exocytosis  mediated 
by exocyst complex and IQGAP1 protein (Sakurai-Yageta et al., 2008). The internalization 
of MT1-MMP can result either in lysosomal degradation, or in the recycling of the protein 
to the plasma membrane.The cytoplasmic domain of MT1-MMP (20 aa) and in particular 
a Leucin motif (LeuLeuTyr573), is responsible for the clathrin-mediated endocytosis by 
its interaction with AP2-clathrin adaptor complex. On the other hand, several studies have 
demonstrated the association of MT1-MMP with caveolae, which are important for the 
correct localization and function of the protease during cell migration (Galvez et al., 2004). 
The endocytosis of MT1-MMP can be regulated by the binding of the protease with its 
principal inhibitor TIMP-2. The internalization of the complex results in a dissociation of 
MT1-MMP from TIMP-2 allowing the protease to be recycled to the plasma membrane. 
The internalization can be also affected by FAK that interferes with the fissation of en-
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docytic membranes and caveolae (Baldassarre et al., 2003). The transport of MT1-MMP to 
invadopodia is mediated by exocytosis regulated by Cdc42 and RhoA (Sakurai-Yageta et 
al., 2008). In addition, aggregation of both F-actin and cortactin enhances and controls the 
accumulation of the protease at invasive structures. MT1-MMP traffic is finely regulated 
by several mechanisms. This suggests that invadopodia are specific domain of the plasma 
membrane that are targets of MT1-MMP exocytosis and where MT1-MMP endocytosis is 
reduced with respect to the other regions of the membrane (Poincluox et al., 2009).
1. 4 Liprin Family
1.4.1 Liprin subfamilies and isoforms 
Liprins are cytosolic scaffold proteins involved in the regulation of synapse assembly 
and maturation, vesicular trafficking and cell motility (Zurner et al., 2011). These pro-
teins localize mainly at the plasma membrane. Liprin proteins are classified into α- and 
β-types based on their sequence similarities (de Curtis, 2011). In vertebrates four liprin-α 
proteins have been identified, (Liprin-α1-4) and two liprin-β (liprin-β1 and β2) (Ser-
ra-Pages et al., 1998). Different liprin-α proteins have a 60-75% of sequence identity 
while liprin-β1 and liprin-β2 proteins are about 51% identical and about 28% identical 
to liprin-α family members.
The genomes of C.elegans and Drosophila encode a single gene homologous to human 
liprin-α1, termed synapse-defective-2 (syd-2) and Dliprin, respectively (Kaufmann et al., 
2002; Zhen and Jin, 1999). Drosophila genome also encodes a single homolog of human 
liprin-β proteins, CG11206, (Serra-Pages et al., 1998), and a third protein called liprin-γ 
that has approximately equal homology to liprin-α and liprin-β (Astigarraga et al., 2010). 
Northern blot and quantitative RT-PCR analysis from different mammalian tissues reve-
aled that liprin-α1 is ubiquitously transcribed with the low levels of gene expression in 
the brain (Zurner and Schoch, 2009), while liprin−α2 and liprin−α3 are mainly expressed 
in this organ. Liprin−α4 is mostly expressed in muscle and testis and at lower levels in 
brain, lung, heart and thymus (Serra-Pages et al., 1998; Zurner and Schoch, 2009). Li-
prin-β1 and Liprin-β2 are widely expressed in human tissues (Stafford et al., 2011). All 
the liprin genes are regulated post-transcriptionally by alternative splicing events (Zurner 
and Schoch, 2009; de Curtis, 2011). A recent comparative analysis between human and 
mouse liprin-α genes has shown a high homology in the sequence and the placement of 
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exons and in the size of introns between species, indicating strong evolutionary conser-
vation (Zurner and Schoch, 2009). It has been also reported that liprin-α1 is the family 
member with the highest number of splice variants. Alternative splicing in liprin-α4 gene 
leads to proteins with different C-terminal regions. Also Liprin-α2 and Liprin-α3 undergo 
alternative splicing in the C-terminal portion, specifically upstream the second steril–α 
motifs (SAM2 domain) (Zurner & Schoch, 2009), a region that mediates the interaction 
with other proteins. Thus, the alternative splicing is important to determine the specific 
interaction properties of each liprin isoform (de Curtis, 2011).
1.4.2 Liprins structure
Both liprin-α and liprin−β proteins consist of an aminoterminal coiled coil region that 
mediates homo- and heterodimerization, and a carboxy-terminal region of 250 aminoaci-
dic residues, named liprin homology (LH), that show high degree of conservation among 
isoforms and contains three steril-alpha motifs (SAM domains) (Fig1.12) (Serra-Pages 
et al., 1998). SAM domains are placed in tandem and mediate the interaction with either 
proteins, RNA or lipid membranes (Qiao and Bowie, 2005). The most widely expressed 
liprin-α, liprin-α1, is composed by 1202 aminoacids and has a weight of 160 KDa, it is 
the only family member with a PDZ-binding domain at the carboxy-terminal and with a 
peptide (PEST sequence) placed between the N-terminal coiled coil region and C-terminal 
SAM region. The PEST sequence mediates the protein degradation by calcium/calmodu-
lin-dependent protein kinase II (Hoogenraad et al., 2007; Sheng et al., 2007). Liprin-β1 
and liprin-β2 are composed by 1011 and 876 amino acids respectively, and their N-ter-
Fig 1.12  Scheme of the structure of liprin-a and liprin-b. Liprin-a proteins include an ami-
no-terminal coiled-coil region (CC) responsible for the formation of liprin-a dimers, and of a car-
boxy-terminal region including three SAM (steryl a motifs) and a carboxy-terminal PDZ-binding 
sequence (VRTYSC), which is missing in some liprin-a isoforms. Similarly, liprin-b include an 
amino-terminal coiled coil-rich region, shorter than in liprin-a1, and three carboxy-terminal SAM 
domains. Adapted from de Curtis, 2011.
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minal coiled coil regions are significantly shorter than in liprin-α proteins (R.L Stafford 
et al, 2011). All liprin-α proteins coiled coil regions are able to interact with each other 
but not with liprin−β proteins. In particular, it has been reported that liprin-α1 manly for-
ms either homodimers or heterodimers with liprin-α2 through its amino-terminal portion 
(Fig 1.13A) (Serra-Pages et al., 1998). At the same time, all liprin-β proteins coiled coil 
regions are able to interact with each other. Liprin-βs can interact with liprin−α members 
through the C-terminal portion. Crystallographic studies on liprin-β2 coiled coil region 
have shown that the N-terminal portion of the protein mainly forms a dimer with paral-
lel orientation. Moreover, this parallel dimer arrangement likely determine that all six 
C-terminal SAMs are positioned next to each other (R.L Stafford et al, 2011). Further 
crystallographic studies have indicated that SAMs domains are connected by H-bonding, 
hydrophobic and charge-charge interactions.  The residues that connect SAM1 to SAM2/3 
are highly conserved among liprin proteins, indicating that the head-to-tail assembly of the 
three SAMs is common to all the α and  β molecules (Wei et al., 2011). Moreover, it has 
been demonstrated that the SAM domains form a supramodular structure responsible of 
the interaction properties of the proteins. In this respect, an important difference has been 
identified between the SAM repeat in α and  β− proteins. The β1 region lacks an alpha 
helix included in liprin-α1 SAM1, whereas liprin-β1 presents an additional helix at the 
Fig 1.13 Models of interaction between liprin-a and liprin-b proteins. (A) A parallel homodimer 
model of the complete liprin-β2. (B) The “closed dimer” model of interaction between liprin-α1 and 
liprin-β2 molecules. The three tandem SAM domains of liprin-as interact with liprin-bs (C) An alter-
native “open scaffold” model is shown in which multiple a- and b-liprins stack indefinitely. In both 
“closed dimer” and “open scaffold” models the coiled-coil domains are predicted to radiate from the 
central interacting SAM domains. Adapted from Stafford et al., 2011.   
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C-terminus of its SAM3 domain (Wei et al., 2001). This structural difference may deter-
mine the different target interaction properties of the two liprins subfamilies. Based on the 
orientation of the coiled coil region and the structure formed by the SAMs domains, two 
models for the interaction of liprin-α with liprin-β proteins have been proposed: the closed 
dimer and the open scaffold model. In the first model SAM domains of liprin-β s and li-
prin-α’s may come together by tail to tail interaction (Fig 1.13B). In the second model the 
the SAM domains of one α-dimer interact with SAM domains of two different β-dimers 
(Fig 1.13C), potentially creating large multiprotein complexes (Wei et al., 2011).
1.4.3 Liprins functions
Liprin-α1 has been identified for the first time in fibroblasts, as an interactor of LAR, a 
transmembrane tyrosin phosphatase with a role in axon growth (Dunah et al., 2005), cell 
adhesion and migration (Serra-Pages et al., 1998). Following studies have dissected the 
role of liprin-α proteins mainly in C.elegans and mammalian neuronal system, reporting 
their involvement in the assembly and regulation of the pre-synaptic active zone (Zhen 
and Jin, 2004), pre-synaptic vesicle trafficking (Zhen and Jin, 1999; Ko et al 2003b), 
but also in post-synaptic regulation with LAR (Dunah et al., 2005). More recently, it has 
been demonstrate the involvement of liprin-α proteins in the regulation of exocytosis in 
non-neuronal system, such as mast-cells (Nomura et al., 2009) and spermatozoa (Joshi et 
al., 2012), and in the regulation of cell motility in non-tumoral and tumoral cells (Asperti 
at al., 2009; Astro et al., 2011; Astro et al., 2014). Differently, only few data on the speci-
fic functional role of liprin-β proteins have been published. The specific roles of liprin-α 
and liprin-β proteins are discussed below.
1.4.3.1 Liprin-b  proteins function
Liprin-β proteins have been identified as interactors of liprin-α1 protein by trap inte-
raction screening (Serra-Pages et al., 1998). As for liprin-α proteins, some studies iden-
tified a possible role of liprin-β proteins in both neuronal and non-neuronal system, even 
if the data available are less than the data published about liprin-β proteins. Recently a 
single homologous of human liprin-β protein has been described in Drosophila. It forms 
homodimers via the N-terminus, and interacts with liprin-α through its C-terminal portion 
(Astigarra S., et al., J.Neurosci. 2010). These authors observed that liprin-α and liprin-β 
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have a synergistic function in Drosophila synaptogenesis although the mechanism and 
the contribution of each protein activity is different. Indeed, it has been demonstrated 
that both liprin proteins are needed to terminate the axon growth in response to target 
recognition even if in liprin-α mutants, the axon stops growing and remains in or retracks 
back to the target layer, while in liprin-β mutants a small percentage of axons maintain 
the capacity to extend projections but results in a less stable synapses formation. This 
indicates that liprinβ protein contributes to stabilize synapses. Moreover, it has been ob-
served that liprin-β mutants cause reduced size of neuromuscular junction (NMJ) and 
affects bouton formation. This suggests an involvement of liprin-β in NMJ function (Asti-
garra et al., 2010). More recently, it has been described that liprin-β1 may interact with 
S100A4 at plasma membrane of cellular protrusions in non-neuronal cells (Kriajevska et 
al 2002). S100A4 is a small calcium binding protein that participates in various cellular 
processes such as transducer of calcium signal. Since S100A4 is strongly expressed in 
undifferentiated types of cancer even at metastatic level, it was suggested that S100A4 
acts as a modulator of liprin-α1/liprin-β1 complex formation, to influence cell adhesion, 
migration and invasion (Kriajevska et al, 2002). Another study has reported that liprin-β1 
is highly expressed in lymphatic vasculature and that liprin-β1 silencing results in edema. 
This suggests an involvement of liprin-β1 in the development and integrity of lymphatic 
vasculature (Norrmén et al., 2009). 
A more recent study has shown that liprin-β1 forms a protein complex with liprin-α1, 
KANK1 and KIF21A, which cooperates with LL5β, ELKS and CLASP proteins in cor-
tical microtubules organization (van der Vaart et al, 2013). It has been also demonstrated 
that liprin-β1 immunoprecipitates with ELKS and liprin-α1, and immunofluorescent stai-
ning showed that endogenous liprin-β1 displays a significant colocalization with these 
proteins and LL5β (van der Vaart et al, 2013). Since it has been reported that the complex 
formed by liprin- α1, ELKS and LL5β plays an important role in the regulation of tumor 
cell migration and invasion (Astro et al., 2014), it may be hypothesised the involvement 
of liprin-β1 also in these same processes. However, it has not been demonstrated, yet.  On 
the other hand, some authors have found that the silencing of liprin-β2 promotes tumoral 
cell invasion and increases the speed of cell migration. On the contrary, liprin-β2 ove-
rexpression causes a decrease in cell invasion (von Thun et al., 2011). Altogether, the data 
available on liprin-βs support the hypothesis of the involvement of these proteins in cell 
motility, possibly in the same processes in which liprin-α1 is involved. However, studies 
are needed to confirm these speculations.
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1.4.3.2 Liprin-a function in neuronal cells
Liprin-a proteins have mainly been studied in the neuronal system, where they appear to 
be involved in several processes at both the pre-synaptic and post-synaptic level (Wentzel 
et al., 2013; Owald et al., 2012) (Fig. 1.14). Different studies have shed light on the diffe-
rent expression pattern of the four liprin-a in rat and mouse brain (Spangler et al., 2011: 
Zürner et al., 2011). It has been found that all four proteins are expressed in postnatal and 
adult rat brain, albeit the expression pattern and levels are different for each isoform. Li-
prin-a1 has been detected at very low level, except for the cerebellum and hippocampus 
where it is enriched in dentate gyrus. Liprin-a2 and liprin-a3 are mainly expressed in the 
postnatal brain in the outer layers of the cortex, in hippocampal cornu ammonis region 
(CA) and in the thalamus. The two proteins are detected at high levels also in the adult 
brain. The former protein is predominant in the olfactory bulb granules dentate gyrus, 
cerebellar granule cells, and amygdale nucleus. Liprin-a3 is expressed at higher level 
in hippocampus, cortex and cerebellar granule cells. Liprin-a4, is poorly expressed in 
the adult brain except for the cerebellum and the hippocampus. Furthermore, it has been 
Figure 1.14. Schematic representation of liprin-α1 recruitment at the presynaptic active 
zone in neurons. In synapses liprin-a1 is involved in the assembly and organization of a functio-
nal presynaptic active zone. Liprin-a1 interacts with other proteins, such as ELKS/ERC, RIM and 
Piccolo. (Grey lines) protein interaction; (Green circles) scaffolding proteins; prenylated Rab ac-
ceptor (PRA); Ras-related in brain (Rab); synaptosome associated protein (SNAP); Voltage-de-
pendent Calcium Channel (VDCC). Adapted from Mittelstaedt et al., Biol. Chem., 2010.
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observed that syd-2, the C. elegans homologous of liprin-a, is expressed in both neurons 
and muscles, where it is localized at the centre of pre-synaptic active zone. Syd-2 mutants 
show a significant increase in the area of the active zone but a decrease in its electron 
density. This effect could be rescued by the overexpression of syd-2 in neurons, but not 
in muscles, supporting a specific pre-synaptic role of this protein. Mutations in syd-2 
result in altered presynaptic vesicle clustering (Zhen and Jin, 1999). Several studies have 
demonstrated that liprin-a could interact with different proteins involved in the formation 
and regulation of the active zone (Zhen and Jin, 2004). For example, the liprin-a N-ter-
minal region interacts with Rab3 interacting molecules-a (RIM-a, Schoch et al., 2002), 
ERC/ELKS (ELKS-Rab6-interacting protein-CAST), MALS/Veli-Cask-Mint1 complex 
(Olsen et al., 2005), and Kif1a (Shin et al., 2003). In particular, RIM proteins regulate sy-
naptic vesicle release. ERC family members influence the sub-localization of both liprin 
and RIM, and some data suggest that liprin-ERC/ELKS interaction may regulate the sur-
face delivery of vesicles (Ko et al 2003b, Ohtsuka et al 2002). It has been proposed a mo-
del in which syd-2 recruits ERC-1/ELKS and other proteins to promote the assembly of a 
new presynaptic specialization. Subsequently the syd-2/Liprin-a ERC/ELKS-1 complex 
would bind RIM and other proteins allowing synaptic vesicle docking and priming (Dai 
et al., 2006). The MALS/Veli-Cask-Mint1 complex regulates the transport of presynaptic 
vesicles from the reserve pool to the releasable pool. Liprin-a can also bind KIF1A, a 
neuro-specific motor belonging to the kinesin superfamily (KIF) that is able to transport 
cargo vesicles along the microtubules (Hirokawa & Takemura, 2004). Liprin-a could 
link KIF1A to diverse kind of proteins either membrane-associated, cytoskeleton-asso-
ciated or signalling proteins, to allow them to reach the presynaptic terminal (Shin et al., 
2003). More recently, it has been identified a region of 107 amino-acids (aa 92-199) in 
the N-terminal portion of syd-2/Liprin-a  named LH1 domain (Liprin homology domain 
1) that is required for the function of this protein in presynaptic assembly and is sufficient 
to restore synaptic assembly in syd-1 defective mutants (Taru and Jin, 2011). There is 
evidence supporting the importance of liprin-a2 as a regulator of presynaptic function 
and dynamics in mature hippocampal synapses: it controls synaptic output and synaptic 
protein composition, regulating the synaptic vesicle pool. Moreover, liprin-a1 undergoes 
an activity-dependent regulation: low neuronal activity reduces liprin-a2 levels, while 
high neuronal activity causes an increase of liprin-a2 expression (Spangler et al., 2013). 
In light of these results, it becomes evident a specific role of liprin-a proteins in synaptic 
vesicle transport along microtubules and in the control of vesicle trafficking, and exocyto-
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sis of neuropeptides at synaptic sites, although the precise underlying mechanisms are 
not fully elucidated. Some studies have identified a postsynaptic role of syd-2/Liprin-a, 
showing that at this site liprin-a binds GRIP (Wyszynski et al., 2002), LAR (Dunah et al., 
2005) and GIT/Cat/p95-APP/PKL (Ko et al., 2003a). LAR is important at postsynaptic 
sites since its depletion causes loss of synapses and dendritic spines (Dunah et al., 2005) 
The LAR/liprin-a/GRIP interactions are essential for the dendritic targeting of the cadhe-
rin–b-catenin complex and AMPA receptors. LAR complex promotes not only the synap-
tic accumulation of b-catenin, but also the adhesive function of the cadherin/b-catenin 
complex at synapses. GIT1 regulates endocytosis of various membrane proteins, like the 
b2-adrenergic receptor (Premont et al., 1998; Claing et al., 2000). It has been described 
that the interaction of GIT1 with liprin-a is essential for AMPA receptor targeting (Ko 
et al., 2003). 
1.4.3.3 Liprin-a in exocytosis
Although Liprin-a proteins have been mainly studied in the neuronal system, they are wi-
dely expressed and there are increasing evidences showing their role in different processes. 
1.4.3.3.1 Liprin-a in mast cell
The principal role of active zone is the release of neurotransmitter by exocytosis. Proteins 
involved in neuronal exocytosis are also expressed in other tissues, for example mast cel-
ls that are specialized in the release of inflammatory mediators. Nomura and colleagues 
found that ERC/ELKS is expressed in mast cells where it regulates positively the exocytic 
process (Nomura et al., 2009). More recently, the same authors have investigated the 
expression and the role of liprins in the same cells where liprin-a1, liprin-a2 and liprin-a3 
are expressed. These authors have observed that liprin-a1 colocalizes with ERC/ELKS 
in the cytoplasm, and that liprin-a1 silencing impairs the exocytic release and a signifi-
cant decrease of the cell area. These data indicate that liprin-a1 is a positive regulator of 
exocytosis and cell spreading of mast cells (Nomura et al., 2011).
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1.4.3.3.2 Liprin-a in spermatozoa
The acrosomal reaction (AR) is the secretory event in the spermatozoa that is needed for 
the fertilization of the egg. Acrosome biogenesis is a multistep process in which the Gol-
gi apparatus constantly secretes vesicles that fuse to form the acrosome. The acrosomal 
reaction is indispensable for a correct fertilization (Joshi et al., 2012). Several studies 
have compared acrosomal reaction to the vesicle exocytosis in synapses. For example, 
it has been demonstrated that diverse membrane-associate proteins like synaptotagmin, 
synaptobrevin, SNAP-25, RIM and Rab3A are involved in both the processes (Michau et 
al., 2011, Zitranski et al., 2010, Bello et al., 2012, Iida et al., 1999, Katafuchi et al., 2000). 
Recently, it has been reported the expression of liprin-a3 and LAR in rat testis, epidi-
dymis, mouse and human spermatozoa (Joshi et al., 2013). Liprin-a3 colocalizes with 
LAR and RIM on the anterior part of the acrosome in mouse spermatozoa and depletion 
of liprin-a3 though liprin-a3 leads to a inhibition of the acrosomal reaction, thus af-
fecting fertilization (Joshi et al., 2013). Moreover, it has been demonstrated that during 
the first phases of acrosome biogenesis liprin-a3 is associated to the Golgi, supporting the 
hypothesis that liprin-a3 is an acrosome-associated (Joshi et al., 2012; Joshi et al., 2013).
1.4.3.4 Liprin-a role in cell adhesion and motility: regulation cell spreading and 
FA dynamics regulation
Cell motility is a multistep process that requires cell spreading and the formation of new 
adhensions. Liprin-a1 is positive regulator of cell spreading: in 2007 Shen and colleagues 
demonstrated that liprin-a1 silencing in RKO cells suppressed cell spreading compared 
with controls (Shen et al., 2007). Previous work from our laboratory has confirmed these 
effects and has tried to elucidate the mechanisms by which liprin-a1 regulates cell sprea-
ding and motility. Initially, it has been shown that in COS7 cells liprin-a1 localizes at the 
periphery of the cells, and it is stably associated to the cytoplasmatic side of the ventral 
plasma membrane (VPM) derived from ECM-attached cells. The endogenous protein is 
enriched at the cell membrane together with talin, and partially co-localizes with more 
mature, central focal adhesions (Asperti et al., 2009). During cell spreading, it has been 
observed that liprin-a1 only partially co-localized with the newly formed focal adhesions 
at the edge of the cells. In fact, the costaining with paxillin and talin indicated that li-
prin-a1 localizes just behind the new adhesion sites. Talin is a protein that links integrins 
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to the actin cytoskeleton and regulates integrin activation (Jiang et al., 2003). Indeed, the 
interaction between talin and the cytoplasmatic tail of integrins leads to a conformational 
change that increases the affinity of integrins for their extracellular ligands, mediating the 
cell spreading (Zhang et al., 2008). 
Supporting the role of liprin-a1 in cell spreading, it has been observed that its overexpres-
sion strongly increases spreading by enhancing the formation of new actin lamellipodia. 
Furthermore, liprin-a1 overexpression leads to a redistribution of the newly formed focal 
adhesions that were enriched at the periphery of the cells. Finally, in liprin-a1 overexpres-
sing cells, it has been observed an increase of Rac1 activity after 30 minutes of spreading 
on fibronectin (FN) while the co-expression of liprin-a1 with a Rac1 dominant negative, 
(N17Rac1 mutant) causes inhibition of spreading. These data indicate that the effects of 
liprin-a1 overexpression on cell spreading are mediated by the activity of the GTPase 
Rac1 (Asperti et al., 2009). Interestingly, liprin-a1 overexpression leads to an accumula-
tion of activated b1-integrin at the cell edge whereas the overexpression of talin does not 
affect spreading but enhances b1 integrin activation. However, the co-transfection of li-
prin-a1 and talin1 prevents both liprin-a1 enhanced spreading and talin-induced integrin 
activation. Altogether, these data indicate that liprin-a1 and talin influence each other 
and cooperate in the regulation of cell motility (Asperti et al., 2009). The LAR protein 
is implicated in liprin-a1-dependent spreading: LAR depletion inhibited spreading also 
in cells overexpressing liprin-a1. In these conditions, the redistribution of b1-integrin 
in liprin-a1 overexpressing cells is not affected, indicating that liprin-a1 and LAR are 
involved in the same pathway with distinct roles: liprin-a1 and LAR are indispensable 
for cell spreading, but LAR is not required for liprin-a1 regulation of peripheral active 
of bintegrins. Further analysis on the role of liprin-a1 in controlling the FA dynamics has 
shown that in liprin-a1 overexpressing cells it occurs a re-localization of inactive integrin 
b1 but not of the active integrin pool, and that liprin-a1 colocalizes with inactive integrin 
b1 at the VPM of adherent cells (Asperti et al., 2010). Likewise, in chicken embryo fibro-
blasts (CEF) liprin-a1 overexpression induced the formation of a greater number of FAs, 
larger in size with respect to the control cells. Interestingly, liprin-a1 depletion leads to 
a faster internalization of integrin-b1 while liprin-a1 overexpression stabilizes integrin 
receptor at the cell surface, resulting in reduced internalization. Based on these finding 
it has been proposed a model in which liprin-a1 promotes cell motility, stabilizing the 
inactive integrins at the cell periphery and making them available for the formation of 
new FA (Asperti et al., 2010). 
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1.4.3.5 Liprin-a function in migration and invasion
Recently, it has been shown that liprin-a1 interacts with inhibitor of growth 4 (ING4) 
that is a candidate tumor suppressor playing a role in gene regulation, cell cycle control, 
apoptosis and angiogenesis (Shen et al., 2007). The ING protein family consists of five 
members (ING1-5) located on different chromosomes close to the telomeres (D. Ythier et 
al., 2008). The ING genes are conserved during the evolution supporting the hypothesis 
of the involvement of ING proteins in important cellular functions (G. H. He et al., 2005). 
In particular, it has been described that ING4 plays a role in cell migration. Indeed, ING4 
overexpression impaires cell spreading and migration while its depletion promotes cell 
motility (M. Unoki et al., 2006).
Some studies have observed a loss of ING4 protein or a decrease of its mRNA levels in 
several tumors such as hepatocarcinoma, melanoma, gastric, ovarian, colon, brain and 
breast cancer (C. Guérillon et al., 2014). The observation that ING4 could affect cell 
migration through liprin-a1, has led to the hypothesis that liprin-a1 could be directly 
involved in tumor cell motility (JC Shen et al., 2007).
Interestingly, studies from our laboratory have found that liprin-a1 protein is frequently 
overexpressed in human breast cancer (Astro et al., 2011). Trying to dissect the role of 
liprin-a1 in tumor cell invasion and migration, it has been observed that this protein is es-
sential for the stability of lamellipodia in a human breast cancer model (MDA-MB-231), 
affecting both cellular migration and invasion (Astro et al., 2011). Specifically, it has been 
shown that liprin-a1 depletion impairs lamellipodia dynamics, leading to an increase of 
the number of lamellipodia formed per cell but a decrease of the lamellipodia persistence. 
This data suggested that the defect of lamellipodia persistence may cause the defect in 
cell migration.
Further results have shown that liprin-a1 silencing reduces cell invasion through Matrigel 
and ECM degradation causing a decrease in the number of invadopodia formed per cell. 
In fact, time-lapse experiments on cell transfected with DS-Red-Cortactin and liprin-a1 
siRNA have demonstrated a reduced lifespan of invadopodia in liprin-a1-depleted cells 
(Astro et al., 2011).  Since liprin-a1 is a scaffold protein, it is reasonable to hypothesize 
that it does not act alone in controlling cell motility. Indeed, two recent studies have shown 
that liprin-a1 forms a complex with ERC1, LL5b, KANK1 and KIF1A (Van der Vaart et 
al., 2013, Astro et al., 2014). In particular, it has been demonstrated that ERC1 and LL5b 
colocalize with liprin-a1 at the front of migrating cells and cooperate with liprin-a1 in 
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the regulation of tumor cell migration and invasion. Time lapses analysis reveals that the 
silencing of either liprin-a1, ERC1 or LL5b proteins decreases the stability of lamellipo-
dia whereas their overexpression reduces the frequency but increases the stability of the 
protrusions. Interestingly, all the three proteins are required for the efficient endocytosis 
of b1 integrin, suggesting that this may affect cell motility (Astro et al., 2014).
1.4.5 Liprin binding proteins
As mentioned, liprin-α1 protein has been firstly identified by interaction trap assay in human 
fibroblasts studying potential partners of LAR (Serra-Pages et al., 1998). Moreover, several 
studies on have shown that liprin-α1 interacts with other proteins (Fig 1.15) such as ERC1 
(Ko et al., 2003), GITs (Kim et al., 2003), CASK (Wei et al., 2011), KIF1a (Shin et al., 2003) 
and RSY-1 (Patel and Shen, 2009). In particular, recent studies have demonstrated that LAR 
and GIT1 cooperate with liprin-α1 in the regulation of cell spreading (Asperti et al., 2011). 
On the other hand, Erc1a and its interactors LL5’s form a complex with liprin-α1 coopera-
ting together in the regulation of tumoral cell migration and invasion (Astro et al., 2014).
Fig 1.15 Scheme of liprin proteins and their binding partners. Scheme of the identified inte-
ractors of liprin-a1. Arrows indicate intermolecular interaction, the segments indicate the identified 
protein regions involved in the indicated interactions. Adapted from de Curtis, 2011.
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1.4.5.1 LAR protein
Tyrosine phosphorylation of signalling molecules, adaptor proteins, and cytoskeleton-as-
sociated proteins is associated with different cellular processes such as activation, prolife-
ration and migration (Clark and Brugge, 1995; Pulido et al., 1995) Early adhesion events 
depend on tyrosine phosphorylation and are consequently regulated by dephosphoryla-
tion from phosphatases (Guan et al., 1991). A family of phosphatases, the receptor pro-
tein-tyrosin-phosphatases (RPTPases), includes members with an extracellular region 
connected by a transmembrane portion to a cytoplasmatic part with a PTPase domain 
(Pulido et al., 1995). These proteins play a role in the transduction of signals from the 
extracellular environment. The extracellular region of several RPTPases includes Ig-like 
domains and FN-domains (Streuli et al., 1988). This architecture has been found also in 
adhesion molecules and in receptor for growth factors, and indicates that RPTPases re-
gulate cell-cell and cell-matrix interactions (Pulido et al., 1995). LAR is a member of a 
subfamily of RPTPases (Serra-Pages et al., 1995) that includes three vertebrate homolo-
gue, LAR, RPTP-sigma, and RPTP-delta, as well as few invertebrates orthologue such as 
Dlarb (Chagnon et al., 2004). In the cytoplasm, the LAR pro-protein is cleaved into two 
subunits (P and E-subunit) that are then associated at the cell membrane by non-covalent 
bonds (Streuli et al., 1992). The P-subunit contains a small portion of extracellular region 
of the protein, the transmembrane region and the PTPase intracellular region that includes 
D1 and D2 domains. The D2 domain is responsible for liprin-α interaction with LAR, 
while the D1 domain is catalytic (Streuli et al., 1992). The P-subunit is shorter than the 
E-subunit. The E-subunit constitutes the extracellular portion of the protein, and includes 
a cell adhesion domain with three Ig-like domains and eight FN-III domains (Streuli et 
al., 1988). Together, Ig domains and FN-III domains form the CAM-like extracellular 
region of the receptor, commonly found in several other adhesion proteins (Streuli et al., 
1992). Northern blot analysis has shown that LAR is expressed in human heart, brain, 
lung, kidney, pancreas, placenta, but not in skeletal muscle. In brain, it has been observed 
the expression of a splice variant of LAR indicating that this protein undergoes alternative 
splicing in a tissue-specific manner (Pulido et al., 1995). LAR protein has many functions: 
it transduces cell-cell adhesion signalling and cell-ECM signalling, can control actin or-
ganization (Beltran & Bixby, 2003), and it is responsible for the dephosphorylation of fo-
cal adhesion proteins, thus regulating focal adhesion turnover (Serra-Pages et al., 1998). 
Moreover, LAR regulates cell adhesion and migration through the desphosphorylation of 
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Trio, a GEF for Rac and Rho (Debant et al., 1996) and EphrinA2, a tyrosine kinase recep-
tor involved in the axon (Wilkinson, 2000). Serra Pagés and colleagues have shown that 
the interaction between LAR and liprin-α1 is mediated by the D2 distal PTPase domain 
of LAR and involves the second SAM domain of liprin-α1 (Serra-Pages et al., 1995; Ser-
ra-Pages et al., 1998). It has been demonstrated that LAR cooperates with liprin-α1 in the 
regulation of cell spreading on FN, since LAR depletion causes a decrease of the cell area 
(Astro et al., 2011). The loss of the SAM2 domain of liprin-α1 prevents the enhancement 
of cell spreading observed after either liprin-α1 or LAR overexpression, indicating that 
the effect of liprin-α1 on spreading is mediated by the interaction with LAR. On the other 
hand, LAR silencing has no effects on tumor cell invasion, thus suggesting that liprin-α1 
may regulate cell invasion independently from LAR (Astro et al., 2011).
1.4.5.2 GIT family proteins
Arf-GAP proteins form a heterogeneous family characterized by the presence of an Ar-
fGAP domain. Arf-GAP GTPase-activating proteins stimulate the hydrolysis of GTP by 
Arf GTPases (R. J. Hoefen, 2006), small GTP-binding proteins involved in Golgi/ER 
perinuclear membrane trafficking and recycling of plasma membrane components at the 
cell periphery (H. Sabe et al., 2006; A. Spang et al., 2010). There are 31 genes in humans 
encoding proteins with an ArfGAP domain. (PA Randazzo and RA Kahn, 1994). Arf-
GAP proteins have been divided in 10 subfamilies, including the family of GIT proteins. 
The human genome encodes two GIT proteins: GIT1/p95-APP1 and GIT2/p95-APP2/
PKL (Premont et al., 1998). GIT1 is expressed in a unique form while GIT2 undergoes 
alternative splicing in a tissue-specific way (Premont et al., 2000). GIT1 presents at the 
N-terminus an Arf GAP domain, three ankyrin repeats (ANK) that mediate protein-pro-
tein interaction, and a Spa2-homology domain (SHD). The C-terminal region includes a 
coiled coil domain and a paxillin-binding site (PBS) (Paris et al., 2003). GIT proteins bind 
several partners such as PIX family of Rac1/Cdc42 GEF, that forms stable complexes 
with the GIT proteins (Z.S. Zhao et al., 2000), the focal adhesion adapter paxillin (R.T. 
Predemont et al., 2000), and the focal adhesion kinase (FAK) (Z.S. Zhao et al., 2000). 
These proteins have been observed in a complex localized at focal adhesions, and it has 
been suggested that they may be involved in the regulation of membrane trafficking, 
cytoskeleton dynamics and focal adhesion turnover (de Curtis, 2001). At the same time, 
evidence supports the role of GIT proteins in regulating cytoskeletal dynamics during 
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cell spreading and migration (Manabe et al., 2002). For example, GIT proteins play an 
important role in maintaining the directionality of cell movement possibly by recruiting 
Rac1 at the cell edge (R. J. Hoefen, 2006). In fact, the overexpression of a constitutively 
active Rac leads to an increase of GIT1 localization at focal adhesions and at the leading 
edge in lamellipodia. (Manabe et al., 2002). Consistently, the overexpression of GIT1 
enhances cell migration and causes a traslocation of paxillin from focal adhesion to peri-
nuclear vesicles (Zhao et al., 2000). Some studies indicate that GIT1 is a scaffold protein 
for MAP kinase activation, to promote the activation of ERK1/2 at focal adhesions (G. 
Yin et al., 2005). Other studies have hypothesized that GIT1 and GIT2 regulate focal 
adhesion and membrane trafficking in different ways. It has been observed that phospho-
rilation of GIT2 by Src or FAK is necessary for the traslocation of the Nck-PAK-Pix-
GIT2 complex to the adhesion sites and for the regulation of their turnover (MC Brown 
et al., 2005).  Consistently, it has been observed that dowregulation either of Src or FAK 
resulted in the inhibition of GIT2 recruitment at adhesion sites, whereas no effects have 
been observed for GIT1 (Bagrodia et al., 1999). Moreover, GIT1 localizes both at focal 
adhesion as well as along stress fibers, while GIT2 localizes only to paxillin-positive 
focal adhesion (Y. Shikata et al., 2003). GIT complexes play a role also in regulation of 
chemoattractant-induced cell motility and receptor trafficking although GIT1 and GIT2 
seem to control different subsets of agonist-induced responses (M. Gavina et al., 2010). 
In 2003 Ko and colleagues have identified the interaction between both GIT1 and GIT2 
with liprin-a1 by yeast two-hybrid screen. It has been shown that the minimal region of 
interaction between GIT1 and liprin-a1 is the portion of GIT1 including 523-770 amino 
acid residues and residues 513-673 for GIT2 (J. Ko et al., 2003). Furthermore, it has been 
observed that GITs proteins form complexes with both liprin-a1 and liprin-a2. Recently, 
work from our laboratory has demonstrated that liprin-a1 competes with paxillin for the 
binding to GIT1, while liprin-a1 does not interfere with the interaction between GIT1 and 
bPIX (C. Asperti et al., 2011). Moreover it has been shown that both GIT1 and liprin-a1 
play a role during cell spreading in reorganizating the cell edge. The depletion of each 
protein in fact, leads to the inhibition of cell spreading. Finally, the silencing of GIT1 
reverts the positive effect of liprin-a1 overexpression on cell spreading and migration. 
This indicates that the two proteins work in the same pathway during cell migration (C. 
Asperti et al., 2011). Conversely, in a study on the role of liprin-a1 in invasion, it has been 
observed that silencing of GIT/PIX complexes does not influence either cell invasion, or 
migration (Astro et al., 2011).
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1.4.5.3 ERC/ELKS and ELKS-associated proteins
ERC/ELKS has been first identified as a gene fuse to RET, a tyrosin kinase receptor 
rearranged in thyroid papilloma (Nakata et al., 1999). ELKS is also known as Rab6IP2 
(Monier et al., 2002), CAST (Ohtsuka et al., 2002) and ERC (Wang et al., 2002). The 
mammalian genome encodes two Erc proteins: Erc1 and Erc2 (Ko et al., 2003). ERC 
transcript undergoes alternative splicing generating a short isoform that is brain-specific, 
ERC1b, and five ERC1a proteins, with different C-termini: ELKSa, ELKSb ELKSg, 
ELKSd and ELKSe. ELKSa and ELKSb are present in the brain, ELKSg and ELKSd 
are expressed in testis and thyroid while ELKSe is detected also in other tissue. ERC2 is 
brain specific and it is expressed in a unique form. Although both ERC1b and ERC2 are 
neuro-specific, they show a different subcellular localization in neurons (Ko et al., 2003). 
In fact, ERC1b is expressed as a cytosolic protein as well as an active zone component, 
while ERC2 is an active-zone specific protein (Ko et al., 2003; Nakata et al., 1999). Pre-
diction studies on the secondary structure of the peptide indicate the presence of coiled 
coil regions throughout the protein, and a leucin zipper at the C-terminus (Ducut Sigala et 
al., 2004). The C-terminus ends with a PDZ-binding domain (Songyang et al., 1997). The 
interaction between liprin-a1 and ERC1 has been described by Ko and colleagues in a 
neuronal system (J. Ko et al., 2003). The active zone specific protein ERC2 promotes the 
synaptic accumulation of liprin-a, and the two proteins regulate together the trafficking 
of vesicle at the active zone.  
ERC1a (ELKSe) interacts with the active form of Rab6A, Rab6A’, and Rab6B. Rab6 is 
a member of the Rab family, small GTPases that play a role in both retrograde vesicle 
transport from the endosomes to the ER and in anterograde transport, from the Golgi to 
the cell membrane (Monier et al., 2002; Grigoriev et al, 2007). ERC1a interacts with 
Rab6 through a portion of the C-terminus (aa 950-1015) (Grigoriev et al, 2011). Cells 
expressing the Rab6-binding domain of ERC1a (Rab6BD) show a partial inhibition of 
the transport between the Golgi and the plasma membrane, whereas the overexpression of 
the full length of Erc1a protein does not impair the exocytic process (Monier et al, 2002). 
Conversely, ERC1a depletion induces the accumulation of the exocytic Rab6-positive 
vesicles at the cell periphery. ERC1a silencing also affects the fusion of Rab6-positive 
vesicles at the cell membrane. On the other hand, ERC1a depletion impairs neither the 
formation of Rab6 vesicles from the Golgi, nor their movement mediated by microtubu-
le. Finally, ERC1a localizes preferentially at regions of the cell membrane where the 
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docking and fusion of Rab6-positive vesicles occurs (Grigoriev et al, 2007).  
Two other main functions of ERC1a have been described: the involvement in the exocyto-
sis calcium-dependent in PC12 cells through the interaction with RIM (Inoue et al, 2006) 
and the regulation of exocytosis in mast cells and pancreatic b-cells.  (Ohara-Imaizumi & 
Nagamatsu, 2005).
Furthermore, emerging evidence shows that ERC1a is involved in the regulation of cell mi-
gration and invasion through its interaction with liprin-a1 and LL5 proteins. LL5 proteins 
(LL5a and LL5b) have been identified for their interaction with PtdIns3P (PIP3) throu-
gh their C-terminal PH domain (Dowler et al., 2000). It has been reported that LL5 can 
bind signalling proteins by recruiting them in PIP3 enriched membrane areas (Kishi et al., 
2005). Moreover, it has been observed the interaction between LL5, ERC and cytoplasmic 
linker-associated proteins (CLASPs). This complex stabilizes microtubules and positively 
regulates the focal adhesion size (Akhmanova et al., 2001, Lansbergen et al., 2006). In view 
of these data, one hypothesis is that LL5b synchronizes actin filaments and microtubules, 
thus coordinating cytoskeletal components for efficient migration (Takabayashi et al., 2010). 
Fig 1.16 Model for the functional interaction of liprin-a1, Erc1a, LL5 proteins Liprin-a1, Er-
c1a and LL5 proteins colocalize at cortical platforms at the periphery of non-motile cells stabilizing 
microtubules through CLASP. In migrating cells, the three proteins may be recruited at the cell 
membrane, close to the focal adhesion near the protruding edge. They colocalize with dynamic 
structures that are involved in the internalization of b1 integrins, thus contributing to the stabiliza-
tion of lamellipodia and the turnover of focal adhesion sites for efficient migration. Adapted from 
Astro et al., 2014.
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1.4.5.3.1 The liprin-a1/Erc1a/LL5s complex in the regulation of tumor cell motility
Recent studies have demonstrated that liprin-a1, ERC1a and LL5 proteins cooperate 
together to regulate tumor cell migration and invasion affecting lamellipodia dynami-
cs, b1-integrin internalization, focal adhesion turnover, and the organization of cortical 
microtubules (Lansbergen et al., 2006; Van der Vaart et al., 2013, Astro et al., 2014). 
Specifically, these proteins are co-expressed in both invasive breast cancer cell (MDA-
MB-231) and HeLa cells, and it has been shown that they colocalize in cytoplasmatic 
structures concentrated near the active protrusions of migrating cells. The depletion of 
either ERC, LL5s or liprin-a1 inhibits cell spreading, migration on FN and Matrigel in-
vasion. Moreover, their silencing results in increased lamellipodia dynamics, and in the 
inhibition of active b1 integrin internalization. Mutation in the PH domain of LL5 inhibits 
the accumulation of the proteins at the cell edge, and negatively regulates lamellipodia 
stability. Altogether these data indicate that the three proteins are recruited to the plasma 
membrane and may be a part of structures that regulate the stabilization of lamellipodia 
and cell adhesion turnover, two processes fundamental for an efficient migration (Fig 
1.16) (Astro et al., 2014). 
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2 AIM
The study of the mechanisms that underlie the invasive and migratory processes of tu-
mour cells represents a fundamental aim of the research in cancer biology. Cell migration 
is a cyclic process that requires remodeling of the cytoskeleton and cellular polarization. 
The migratory activity of cancer cells is frequently associated with ECM degradation that 
leads to neoplastic cell dissemination. Recent findings have revealed that liprin-α1 is a 
regulator of tumor cell migration and invasion in vitro. Interestingly, the gene PPFIA1 
coding for liprin-α1 protein is frequently amplified in cancer, suggesting that liprin-α1 
has a key role in malignant progression. Liprin-α1 is an ubiquitous scaffold protein that 
interacts with several partners, which in turn participate at events of membrane recycling, 
cytoskeletal reorganization, and adhesion assembly and/or disassembly. 
The first aim of this thesis has been the study of the involvement of liprin-α1 in invasion 
in vivo, investigated by performing two different metastasis assays. These assays were 
performed with cell lines either overexpressing, or depleted of liprin-α1. I evaluated the 
ability of these cell lines to give rise to metastases in the lungs. The results of my work in-
dicate that liprin-α1 is not a regulator of tumor cell growth, but it is specifically involved 
in tumor cell invasion in vivo. 
In the second part of the thesis I focused on the investigation of the role of liprin-β pro-
teins in the liprin-α1-mediated processes. For this purpose I first tested whether liprin-β1 
and liprin-β2 interact with liprin-α1, and then whether their depletion had an effect on cell 
migration and invasion. I demonstrated that liprin-β1 and liprin-β2 have distinct roles in 
cell motility: the first interacts and cooperates with liprin-α1 to promote migration and in-
vasion; the latter does not interact with liprin-α1, acting in an opposite way by inhibiting 
the migratory/invasive potential of the tumor cells.
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3 RESULTS
3.1 Role of liprin-a1 for invasion in vivo
It has been shown  that the PPFIA/liprin-a1 gene is amplified in about 20% of breast can-
cers (Al-Kuraya et al., 2004). In order to understand whether this amplification correspon-
ded to an increased level of the protein, a previous study in our laboratory has included the 
immunohistochemical analysed of 116 human breast cancer samples (Astro et al., 2011). 
Immunohistochemistry for liprin-a1 has revealed an increase of liprin-a1 levels in about 
the 50% of the examined biopsies. Established data have demonstrated the involvement 
of liprin-a1 in breast tumor cell migration and invasion in vitro. In view of these results, 
I have addressed the involvement of liprin-a1 during invasion in vivo. In collaboration 
with the anatomo-pahology unit of the San Raffaele Hospital, I extended the analysis 
by adding new human breast cancer cases. This analysis confirms the increment of the 
liprin-a1 protein levels in the tumor tissue (Fig 3.1). Next, I explored the role of liprin-a1 
in vivo by developing the following experimental plan: I generated stable cell lines with 
liprin-a1 overexpression or down-regulation, characterized them in vitro and then injected 
or transplanted these cells in vivo to test their tumorigenic and invasive potential. The high 
invasive human breast cancer cell line MDA-MB-231 was chosen to generate the stable 
clones. This lineage has been established from pleural effusion from metastatic adenocari-
noma (Brinkley et al., 1980). MDA-MB-231 cells are classified as basal-like subtype due 
to their lack of expression of the estrogen Receptor (ER), progesteron receptor (PR) and 
the transmembrane receptor HER2 and for the expression of the EGF receptor (EGFR) 
(Subik et al., 2010). Basal subtype tumors are often associated with visceral organs meta-
stasis; they are more aggressive and poorly differentiated and have poor prognosis (Yer-
sal et al., 2014). MDA-MB-231 cells are commonly used for invasion study in vitro and 
are regarded as a useful model for experimental metastasis in vivo (D.L. Holliday and V. 
Speirs 2011). Recent studies have also described the use of MDA-MB-231 in orthotopic 
transplantation NOD scid gamma (NGS) mice (E. Iorns et al., 2012).
3.1.1 Analysis of human breast cancer samples
Data from our laboratory have demonstrated an increase of the liprin-a1 protein levels in 
cancer tissues in comparison to healthy tissue (Astro et al., 2011). In collaboration with 
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the Pathology Unit at San Raffaele Institute, I analyzed 142 new human breast samples 
by immunohistochemistry with two different antibodies specific for liprin-a1. We divided 
the samples in three categories based on the intensity of the signal for liprin-a1 (Fig3.1) 
and analyzed the correlation between the levels of liprin-a1 protein and the stage of the 
tumor. The analysis of the new samples confirmed that the expression of endogenous 
liprin-a1 was increase in the majority of the cases (Fig3.1A). Furthermore, in collabora-
tion with professor Fesce of University of Insubria, we investigated by statistical analy-
sis, the possibility of a correlation between liprin-a1 expression levels in biopsies and 
some parameters such as the stage of the tumor, the relapse of the tumor, the linfonodal 
involvement and the expression of hormone receptors. This preliminary analysis did not 
show significative association between the amount of the protein and the diverse aspects 
of cancer probably due to the relative low number of cases analyzed. However, deepen 
analysis are required to define the relationship between liprin-a1 expression levels and 
the tumor phenotype.
3.1.2 Generation and characterization of cell lines stably overexpressing lip-
rin-a1 
The highly invasive human breast cancer cell line MDA-MB-231 has been chosen as a 
cellular model to generate stable clones of cells overexpressing liprin-α1. The monoclo-
nal cell lines were tested for the rate of proliferation and the ability to migrate and invade 
in vitro. The data regarding the characterization of liprin-α1 overexpressing clones have 
been recently published in Journal of Cell Science (Astro et al., 2014). 
Fig. 3.1 Immunohistochemical analysis of the expression of the liprin-a1 protein in human 
breast cancer. Samples from 142 human breast cancers were analyzed for Liprin-α1 expression 
in tumor cells. The signal for Liprin-α1 is very low in normal tissue within the same samples. 
Signal: 0-1, no/very low, as in sample (B); >1-2, clearly increased in tumor cells; >2-3, strongly 
increased in tumor cells, as in samples (C) and (D).
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3.2.1A Overexpression of Liprin-a1 does not affect MDA-MB-231 cell prolifera-
tion and  viability
MDA-MB-231 cells were transfected with either the pEGFPLiprin-a1 or the pEGFP con-
struct (the latter was used as a control). After selection with G418, liprin-a1 protein le-
vels were analyzed in three independent monoclonal cell lines overexpressing EGFP-Li-
prin-a1 (clones L4, L12 and L17) and in one control clone overexpressing EGFP (clone 
C9) (Fig.3.2A). Cell proliferation rate and viability were tested by growth curve and MTT 
assay, respectively. The results demonstrated that liprin-a1 overexpression did not affect 
either proliferation or cell viability (Fig 3.2 B-C).
Fig 3.2 Proliferation and viability of cell lines overexpressing GFP-Liprin-a1. (A) Immuno-
blotting for endogenous and overexpressed liprin-a1 in control (GFP) and GFP-Liprin-a1 expres-
sing clones in comparison with the wild type (WT) cell line. (B) For the growth curves of the clones 
overexpressing either GFP or GFP-Liprin-a1, 2000 cells/well were seeded in 12 well plates. Cells 
were trypsinized and counted every 24 h (n=4-12 wells) (C) For the measurement of cell viability, 
2000 cells/well were seeded in 96 well plates and the MTT assay was performed every 24 h. Each 
dot represents the average value ± s.e.m., (n=4-6 wells). In both assays, no significant differen-
ces were detected by unpaired Student’s t-test.
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3.1.2.B Liprin-a1 overexpression enhances cell invasion 
In order to characterize the functional phenotype of the clones, I investigated the effects 
of liprin-a1 overexpression on invasion in vitro by using a transwell invasion assay on 
Matrigel. Liprin-a1 overexpression (Fig 3.3A, lane Luc) enhanced the invasive ability of 
the cells in comparison to the control cell line (C9) (Fig.3.3B). The increased invasion by 
these cell lines was prevented by liprin a-1 silencing (Fig 3.3A, lane Lip), confirming the 
specificity of the observed effects (Fig 3.3B). These results confirm the involvement of 
liprin a-1 in breast cancer cell invasion in vitro (Astro, et al., 2011). Moreover, these data 
show that the overexpression of liprin-a1 is able to potentiate the already high invasive 
potential of MDA-MB-2321 cells in vitro.
Fig 3.3 Liprin-a1 enhances human breast cancer cell invasion. (A) Immunoblotting with lip-
rin-a1 antibody on lysates from cells stable expressing either GFP (clone C9, control cell line) or 
GFP-Liprin-a1 (L4, L12 and L17). Cells were transiently transfected with a control siRNA against 
luciferase or siRNA specific for liprin-a1. (B) Transwell invasion assay. Invasion was analyzed af-
ter 5 h at 37°C. Quantification shows enhanced invasion by liprin-a1 overexpressing cells (clones 
L4, L12, L17). Liprin-a1 silencing specifically reduced the invasion abilities of GFP (C9) and 
GFPliprin-a1 overexpressing clones. Bars are normalized means ± s.e.m. (n=6 wells from 3 inde-
pendent experiments). * P<0.05; ** P<0.01. 
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Fig 3.5 Liprin-a1 overexpression in 3D migration. For 3D fibrillar migration, 50.000 cells were 
seeded for 6 h on the top of fibroblast-derived 3D extracellular matrix before imaging. (A) Analysis 
of mean velocity, total distance and persistence of migration evaluated during 8 h with ImageJ 
software. Bars represent normalized mean values ± s.e.m. (n= 72-87 cells per condition, from 
two independent experiments). **P<0.005.  (B) Cell tracking for 8 h of wild-type cell (WT), control 
(C9), and liprin-a1 overexpressing clone (L12, L17). Cells undergoing division and non-moving 
cells were excluded from the analysis. 
Fig 3.4 Liprin- a1 is required for the efficient migration of human breast cancer cells. For 
random migration, 50.000 transfected cells were seeded for 2 h on 2.5 μg/ml FN-coated dishes 
before acquisition by video-imaging. (A) Analysis of random migration: velocity and total distance 
were evaluated during 5 h with ImageJ software. Bars represent normalized mean values ± s.e.m. 
(n= 42-78 cells per condition from two independent experiments). **P<0.005. (B) Cell tracking 
for 5 h of wild-type (WT), control (C9), and liprin- a1 overexpressing cells (L4, L12, L17). Cells 
undergoing division and non-moving cells were excluded from the analysis.
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3.1.2.C Liprin-a1 overexpression enhances both 2D and 3D cell migration
Since liprin-a1 affects cell motility (Asperti et al., 2009), I tested the migratory ability of 
the clones overexpressing liprin-a1 in vitro. Two different approaches were used: 2D ran-
dom migration and 3D fibrillar migration assays. For the 2D migration assay, cells were 
plated on FN coating (2.5 mg/ml) and were free to randomly move in absence of specific 
stimuli. For the 3D fibrillar migration, cells were plated on a fibroblast-derived 3D ECM 
composed mainly of FN fibers, and incubated for 6h to allow them to penetrate the ma-
trix. The presence of the matrix gives some advantages: it creates a more physiological 
environment than 2D substrates. In addition, the fibronectin fibers act as guidelines for 
cell movement, thus allowing the study of the directionality of cell migration along the 
fibrillar meshwork (Cukierman et al, 2001). The results from these two different assays 
were similar: liprin-a1 overexpressing clones showed increased total distance covered 
by the cells both in 2D random migration assay (Fig 3.4 A) and in 3D fibrillar migration 
(Fig 3.5 A). Even though the liprin-a1 depletion led to a decrease in the persistence of 
migration, we did not observe any variation in the directionality in clones overexpressing 
liprin-a1(Fig 3.5). 
3.1.2.D Liprin-a1	overexpression	influences	lamellipodia	dynamics
Previous work in the laboratory demonstrated that liprin-a1 silencing causes an  increase 
in the frequency of lamellipodia formating per cell and a decrease of the average lifespan 
of each lamellipodia (Astro et al., 2011). Consistent with the published data, the analysis 
of lamellipodia dynamics revealed that liprin-a1 overexpression caused a decrease of the 
frequency of lamellipodia formation (fig 3.6 A) but an increase of the average lifespan 
of these protrusions (Fig 3.6 B). These effects were abolished by silencing of liprin-a1 
(Fig 3.6). These observations confirmed that liprin-a1 is a key regulator of lamellipodia 
dynamics. Liprin-a1 plays a role in the stabilization of these protrusive structure that are 
involved in cell migration and invasion.
3.1.3 Generation and characterization of liprin-a1 depleted cell lines.
In several organisms the introduction of double-stranded RNA has proven to be a power-
ful tool to suppress gene expression through a process known as RNA interference (Sharp 
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Fig. 3.6 Liprin-a1 regulates the stability of lamellipodia. Cells overexpressing liprin-α1 (L4) 
and control cells (C9) were analyzed during random migration on FN. Images collected during 
5h of acquisition were quantified using ImageJ. (A) Number of lamellipodia produced in 1h. Cells 
overexpressing liprin-α1 produce (A) less frequent and (B) more stable lamellipodia compared to 
control cells. The effects of liprin-α1 overexpression are abolished by silencing liprin-α1. Bars are 
means ± s.e.m. (n=10 cells per experimental condition). *P<0.05; **P<0.005.
Fig 3.7 Liprin-a1 depletion does not affect cell viability. (A) Levels of liprin-a1 residual ex-
pression detected by western blot. Lane 1: control cell line, lane 2: clone shRNA1-2; lane 3: clone 
shRNA1-5; lane 4: clone shRNA2-1; lane 5: shRNA2-3. (B) For the MTT assay, 2000 cells/well 
were seeded in 96 well plates and viability was measured every 24 h. No significant differences 
were detected by the unpaired Student’s t-test.
Results
— 63 —
Analysis of the role of liprin proteins in breast cancer cell invasion
et al., 1999). However, the reduction of gene expression is transient. To overcome this 
limitation several mammalian vectors were developed to direct intracellular synthesis of 
siRNA-like transcripts. These vectors integrate in the genome to produce a small RNA 
transcript that specifically down-regulates gene expression. In order to obtain MDA-MB-
231-derived cell lines that stably down-regulate liprin-a1, I took advantage of the pSuper 
RNAi system (Brummelkamp et al., 2002). This construct is bicistronic and encodes GFP 
and the neomycin resistance, allowing a double selection both by fluorescence and by 
the use of G418. In order to avoid off-target effects, I designed two independent shRNAs 
based on the sequence of validated siRNAs specific for liprin-a1. The empty pSuper 
vector expressing GFP was used to generate the control line. The shRNAs were cloned 
into the pSuper RNAi vectors and transfected into MDA-MB-231 cells. Monoclonal cell 
lines were obtained by limiting dilution in the selection medium. The clones were firstly 
tested for liprin-a1 silencing (Fig 3.7 A). Cell lines that showed the strongest silencing of 
liprin-a1 were examined for cell viability and invasion in vitro (Fig 3.7 B-3.8).
3.1.3.A Silencing of liprin-a1 does not affect MDA-MB-231 cell proliferation and 
cell viability
I analyzed the residual expression of liprin-a1 in the cell lines obtained. Several clones ex-
pressing either shRNA had a good level of silencing, indicating the high efficiency of the 
transfected silencing plasmid. On the other hand, as expected, transfection of the control 
vector did not affect liprin-a1 expression. In particular, western blots showed that clones 
shRNA1-5 (sh1-5) and shRNA2-1 (sh2-1) had a percentage of liprin-a1 depletion of 88% 
and 98% , respectively (Fig 3.6 A). The MTT assay revealed that liprin-a1 depletion did 
not affect cell viability compared to wild type (WT) and control cells (ctrl) (Fig 3.7 B).
3.1.3.B Silencing of Liprin-a1 affects MDA-MB-231 invasion
The liprin-a1-depleted clones were tested in order to assess their invasive ability in vitro. 
Invasion examined by transwell invasion assay on Matrigel was decreased for cells from 
clones with liprin-a1 silencing compared to cells from the clone transfected with the 
empty vector (Fig. 3.8).
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Fig 3.8 Liprin-a1 silencing inhibites human breast cancer cell invasion. Transwell invasion 
assay with MDA-MB-231-derived clones carrying the silencing vector (sh1-5, sh2-1) or the empty 
vector (ctrl) as well as wild-type cells. Invasion was detected after 5 h at 37°C. Quantification 
shows inhibited invasion by liprin-a1 down-regulation cells (clones sh1-5, sh2-1) in comparison 
with the wild-type (WT) and control (ctrl) cell lines. Bars are normalized means ± s.e.m. (n=4-7 
wells per experimental condition from 2-3 independent experiments). ** P<0.01.
3.1.4 Analysis of the role of liprin-a1 in vivo
To address the role of liprin-a1 in tumor cell invasion in vivo, I used the MDA-MB-231-
derived cell lines described in the previous paragraph to perform metastasis assays in 
vivo. I have utilized for this purpose two different approaches: experimental metastasis 
assay and spontaneous metastasis assay (C. Khanna and K. Hunter 2005).  The difference 
between the two methods resides in the way cells are delivered to the animals. In the first 
approach the tumor cells are injected directly in the systemic circulation, while in the 
spontaneous metastasis assay the tumor cells are transplanted in the anatomic location or 
tissue type from which they have been derived. The two methods give different informa-
tion and in many cases they are complementary (C. Khanna and K. Hunter 2005).
The experimental metastasis assay focuses on the later steps of metastatization: the ability 
of the tumor cells to extravasate and on their ability to survive at distant metastatic sites. 
The site of injection determines the organs that tumor cells will colonize. For example, 
injection in the lateral tail vein results in pulmonary metastasis, intrasplenic and portal 
vein injection results in development of hepatic metastasis, while intracardiac injection 
causes metastasis formation in the bone (A.F. Chamber et al., 2000). The main advantages 
of this approach are the rapid clinical manifestation of the disease and the reproducibi-
lity of the results. I utilized athymic nude female mice as  animal model for this kind of 
experiments according to published protocols (Fig 3.9 A) (M.M. Richert et al., 2005). 
The second approach, modelling the formation of spontaneous metastasis, mimics human 
cancers better, providing information more relevant for host-tumor interactions. Further-
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more, this method gives the opportunity to study the early steps of the metastatic process 
(M.C. Bibby, 2003), and other charateristics of the pathology excluded by experimen-
tal metastasis assay such as primary tumor growth, vascularization, histology and gene 
expression (C. Khanna and K. Hunter, 2005).
The spontaneous metastasis assay consists in the inoculation of tumor cells either sub-
cutaneously, intradermally or orthotopically. This results in the formation of a primary 
tumor that eventually could give rise to spontaneous metastasis (D. R. Welch, 1996). I 
performed orthotopic transplantation of MDA-MB-231-derived cell lines in NOD scid 
gamma (NSG) mice, as indicated in the literature (Fig 3.9 B) (E. Iorns et al., 2012). 
3.1.4.A Liprin-a1 overexpression does not affect lung colonization in experimen-
tal metastasis assay
In order to study liprin-a1 involvement on invasion in vivo, I injected liprin-a1 overexpres-
sing clones (L4, L12, L17), wild type cells and control cells (C9 GFP positive cells) in the 
Fig 3.9 Schedule of the metastasis assays in vivo. (A) Schedule of experimental metasta-
sis assay in vivo. For this approach four-weeks-old athymic nude female mice were used. (B) 
Schedule of spontaneous metastasis assay. For this approach nine-weeks-old female NOD scid 
gamma (NSG) mice were used.
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Fig 3.10 Liprin-a1 overexpression does not affect lung colonization in experimental me-
tastesis assay. (A) Analysis of metastatic area in 16 mm sections from left lungs of four mice 
injected with control cell line (C9 GFP+) as with cells of  a clone overexpressing liprin-a1 (L17). 
Lung metastatic area was calculated as the ratio between the area occupied by the metastases 
and the total area of the section. Values are represented as percentages. The analysis was per-
formed with ImageJ after setting a threshold to define for metastatic areas. Statistical analysis 
was performed with the unpaired t-test. (n=4 mice per experimental group). (B-C) hematoxillin 
and eosin staining of lung sections of mice transplanted with (B) control (C9GFP+) cells or with 
(C) liprin-a1 overexpressing clone L17. Arrows indicate examples of metastases.
lateral tail vein of four-weeks athymic nude female mice (10 mice per experimental group) 
according to published protocols (M.M. Richert et al., 2005). After 4 weeks, mice were sa-
crificed, and lungs were explanted and processed. First, metastases on the surface of left lun-
gs were counted at a dissecting microscope as described in the literature (Kwon et al., 2011). 
The analysis obtained was not sufficiently accurate because the metastases were different 
in size and too close to each other to be discriminated. Under these condition I could not 
observe significant differences in the number of metastatic foci between mice injected with 
liprin-overexpressing clones and control cell lines. To perform a more adeguate analysis, the 
left lung of four mice injected with control cells (C9) and four mice injected with clone L17 
were serially sectioned. Sections spanning the entire lung were stained with hematoxillin 
and eosin to identify the metastases (Fig. 3.10). For quantification, the ratio between the 
metastatic area and the total section area was measured. This preliminary analysis showed 
that liprin-a1 overexpression did not lead to differences in lung colonization in comparison 
with the control cells expressing endogenous levels of liprin-a1 (Fig 3.10).
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3.1.4.B Liprin-a1 overexpression does not affect lung colonization in spontaneous 
metastasis assay
Since the results from the experimental metastasis assay did not show variations in lung 
colonization between mice injected with liprin-a1 overexpressing clones and control cell 
lines, I performed the spontaneous metastasis assay. Differently from the experimental 
metastasis approach, this experiment allows to understand whether liprin-a1 has a role in 
the formation of the primary tumor and its growth, and gives information on the ability 
of tumoral cells to degradate the matrix and to intravasate. Liprin-a1overexpressing cell 
lines (L12 and L17), wild type cells (WT), and control cells (C9, GFP+) were inoculated 
into the fat pad of nine-weeks-old female NOD scid gamma (NSG) mice as previously 
Fig 3.11 Liprin-a1 overexpression does not affect tumor growth and lung colonization. 
Orthotopic transplantation of liprin- a1 overexpressing clones (L12 and L17), wild type (WT) and 
control cell lines (C9-GFP) in NSG mice  (n=10 mice per experimental group). (A) Primary tumor 
growth was measured at 12, 27, 32 and 38 days after transplantation. Significative differences in 
cells tumor growth were detected only between the C9 GFP+ cells and clone L17 cells by unpai-
red Student’s t test (p ). (B) For each animal, the left lung was entirely sectioned and analyzed. 
Average lung metastatic area were represented as percentages. The analysis was performed 
with ImageJ after setting a threshold for the metastatic area. There are no significative differences 
among the experimental groups (unpaired Student’s t test). (C-F) Hematoxillin and eosin staining 
of a representative lung section for each experimental group. Lung sections from mouse tran-
splanted with (C) wild type cells, (D) (C9GFP+) cells, (E) liprin-a1 overexpressing clone L12 cells, 
(F) liprin-a1 overexpressing clone L17 cells.
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described (Mazzieri et al., 2011). Following transplantation, all the animals from each 
experimental group developed primary tumors. Tumor growth was measured four times 
during the experiments, and the growth curve derived from this analysis showed that li-
prin-a1 overexpression did not alter evidently the tumor growth by comparing with the 
tumors derived from control cells lines (Fig 3.11 A). Five weeks after the transplantation 
mice were euthanized, lungs collected, sectioned and analyzed as described for experi-
mental metastasis assay (see methods). Once again, I did not observe difference in lung 
colonization among experimental groups (Fig 3.11 B). 
Considering the high invasive ability of MDA-MB-231 wild type cells, increase in lung 
colonization due to the liprin-a1overexpression may be irrelevant in vivo. For this reason 
the study of the liprin-a1 silencing could be more informative and could highlight differ-
ences dependent on the expression of liprin-a1.
3.1.4.C Liprin-a1 silencing inhibits lung colonization in experimental metastasis 
assay
To study the effects of liprin-a1 silencing in lung colonization, I performed both experi-
mental and spontaneous metastasis assays with liprin-a1-depleted cell lines.
Wild type cells (WT), control cells (ctrl pSEV), and liprin-a1-depleted cell lines (sh1-5 
and sh2-1) were injected into the lateral tail vein of four-weeks-old athymic nude female 
mice (4 mice per experimental group). After 4 weeks, mice were sacrificed and lungs 
were collected and processed as described (see methods). The analysis of lung metastatic 
areas revealed a reduction in lung colonization in mice injected with liprin-a1-depleted 
cells in comparison with mice injected with the control cell lines (Fig 3.12). The two li-
prin-a1-depleted cell lines showed a different efficacy to influence lung colonization. In 
particular, lungs from mice injected with clone sh2-1 presented a  higher variability in the 
metastatic area even though the levels of liprin-a1 silencing were comparable between 
the two injected cell lines. This might be due to the intrinsic variability that characterizes 
in vivo experiments. Experimental metastasis assay was repeated and the reduction in 
metastatic area in mice injected with liprin-a1-depleted cells was confirmed (Fig 3.12 A). 
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3.1.4.D Liprin-a1 silencing affects lung colonization in the spontaneous metasta-
sis assay
The spontaneous metastasis assay was performed to confirm the results from the experi-
mental metastasis assay, in a context that mimics better the metastatic process occurring 
in vivo. Control cells and liprin-a1-depleted cells were inoculated into the fat pad of 
nine-weeks old female NOD scid gamma (NSG) mice (4 mice per experimental group). 
Transplantated cells gave rise to primary tumors in all the mice from each experimental 
group. After transplantation tumor growth was measured four times and the growth curve 
showed that liprin-a1 depletion did not alter the tumor proliferation in comparison with 
the tumors originated by control cell lines (Fig 3.13 A). Five weeks after the transplan-
tation, mice were sacrificed and primary tumors were analyzed by western blot and the 
immunofluorescence confirmed that the silencing of liprin-a1 was maintained until the 
end of the experiment (Fig 3.13 B-C). These data suggest that liprin-a1 is not involved in 
tumor cells proliferation. In support of this hypothesis.
Then I analyzed lung colonization. For this purpose, sections spanning the entire lung 
Fig 3.12 Liprin-a1 silencing affects lung colonization. (A) Analysis of metastatic area in 16 
mm sections from the left lungs of mice injected with wild type cell line (WT), control cell line (ctrl 
pSEV), and liprin-a1-depleted clones (sh1-5 and sh2-1). Statistical analysis is performed with 
unpaired T-test (n=4-8 from two independent experiments). (B-E) H&E of representative section 
for each experimental group. Lung from mice transplanted with (B) wild-type cells, (C) control cell 
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were stained with hematoxillin and eosin to identify the metastases (Fig. 3.14). For quan-
tification, the ratio between the metastatic area and the total section area was measured. 
Mice transplanted with liprin-a1-depleted cells presented a reduction in the formation of 
lung metastasis wheh compared mice transplanted with control cells expressing normal 
levels of liprin-a1. The results obtained in the spontaneous metastasis assays strength-
ened the results obtained with the experimental metastasis assay indicating that liprin-a1 
plays a role in the process of metastasis formation (Fig 3.14). The reduction observed in 
spontaneous metastasis assay was stronger than in the experimental metastasis assay.
Fig 3.13 Liprin-α1-depletion does not affect tumor growth. Orthotopic transplantation of 
liprin-α1-depleted cells (clones sh1-5 and sh2-1), wild-type cells (WT), and control cells (ctrl, 
pSEV) in NSG mice. (A) Primary tumor growth curve: tumor growth was measured at 20, 27, 
34, 36 days after transplantation. No significative differences were detected by the unpaired Stu-
dent’s t test. Western blot analysis and immunofluorescence analysis on primary tumors showed 
that liprin- α1 silencing was maintained during the experiment. (B) Left panel: western blot perfor-
med on each mouse of the experimental group; right panel: quantification of liprin-α1 silencing; 
** P<0.01, * P<0.05. (C) Immunofluorescence on a representative section of control (left) and 
clone sh1-5 (right) primary tumor. Staining with antibody for liprin-α1 (red), and DAPI (blue).
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3.2 Study of liprin-a1 interactors: the liprin-b family members
Previous studies have described the interaction between liprin-a1 and liprin-b proteins 
(Serra-Pages et al., 1998; van der Vaart et al., 2013)  and have suggested a possible role 
of liprin-b1 and liprin-b2 on migration and invasion (Kriajevska et al., 2002; von Thun 
et al., 2012). However, the available data regarding the liprin-b proteins and their rela-
tionship with liprin-a1 are not exhaustive. In order to understand better the mechanisms 
by which liprin-a1 regulates cell motility, I have investigated further the physical inte-
raction between liprin-a1 and both liprin-b1 and liprin-b2 and to address their function 
in tumor cell motility.
Fig 3.14 Liprin-a1 depletion affects lung colonization. Orthotopic transplantation (fat pad) of 
liprin-a1-depleted clones (sh1-5 and sh2-1) and wild-type cells (ctrl) in NSG mice. Left lungs were 
entirely sectioned and analyzed. Average lung metastatic area is represented as percentage. 
The analysis was performed with ImageJ after setting a threshold for metastatic area. Statistical 
analysis was performed with unpaired T-test (n=4 mice per experimental group). (B-D) H&E of 
representative section for each experimental group. Lung from mouse transplanted with (B) wild-
type cells; (C) clone sh1-5; (D) clone sh2-1.
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3.2.1 Biochemical characterization of the interaction between liprin-a1 and 
liprin-b proteins
In 1998 Serra Pagès and colleagues identified liprin-b proteins as liprin-a1 partners by an 
interaction trap assay. They reported that liprin proteins interact through their C-terminal 
regions including the three SAM domains in both liprin-a and -b’s. They also performed 
immunoprecipitation experiments to confirm the data from the trap assay but they could 
not detect the interaction between liprin-a1 and liprin-b1, probably due to the strength 
of the detergent used (Serra-Pages et al., 1998). A recent study confirmed the interaction 
between liprin-a1 and liprin-b1  by co-immunoprecipitation from HeLa cells (van der 
Vaart et al., 2013) while the binding between liprin-a1 and liprin-b2 has been not inve-
stigated, yet. I performed immunoprecipitation experiments with either endogenous or 
overexpressed proteins in order to characterize the binding between alpha and beta liprins.
3.2.1.A Liprin-a1 interacts with liprin-b1 but not with liprin-b2 
To observe the interaction between the endogenous proteins, I performed immunoprecipi-
tation experiments from lysates of MDA-MB-231 cells. The lysates were immunoprecipi-
tated with a monoclonal antibody anti-liprin-a1, then blots were incubated with the same 
antiboby or with antibodies specific for either liprin-b1 or liprin-b2. The results indicated 
the good efficiency of the liprin-a1 antibody used to immunoprecipitate, since liprin-a1 
was depleted from the unbound fraction of lysates (Fig 3.15, UB lane). I could observe 
the interaction between liprin-a1 and liprin-b1  confirming  the published data (Fig 3.15). 
On the contrary, the binding between liprin-a1 and liprin-b2 was not detected, probably 
due to the low levels of liprin-b2 protein in MDA-MB-231 cells. In order to overcome 
the limitation of the low amount of liprin-b2, I performed immunoprecipitation with ove-
rexpressed proteins in COS7 cells. I used this cell line because transfection is more effi-
cient in COS7 than in MDA-MB-231. FLAG-Liprin-a1 was co-transfected with either 
GFP-Liprin-b1 or GFP-Liprin-b2, and biochemical analysis was carried on by immuno-
blotting. The results pointed out that FLAG-Liprin-a1 interacted with GFP-Liprin-b1 but 
not with GFP-Liprin-b2 (Fig. 3.16). This is the first evidence of the different ability of the 
two liprin-b proteins to interact with liprin-a1 even though in literature was hypothesized 
a similar biological behavior for liprin-b1 liprin-b2 , based on their sequence similarity. 
Van der Vaart and colleagues have been reported by that liprin-b1 is a member of  the li-
Results
— 73 —
Analysis of the role of liprin proteins in breast cancer cell invasion
prin-a1 complex, (van der Vaart et al., 2013). I would speculate that liprin-b1 cooperates 
with liprin-a1 in regulating cell motility, whereas liprin-b2 may interact with different 
specific partners acting independently by the other liprin proteins.  
3.2.1.B The interaction between FLAG-Liprin-a1 and GFP-Liprin-b1 is mediat-
ed by SAM domains
The interaction trap assay has shown that liprin-a1/liprin-b1 interaction is mediated by 
the C-terminal SAM domains of the two proteins (Serra-Pages et al., 1998). In order to 
confirm these data, I generated FLAG-Liprin-a1 mutants lacking either the C-terminal 
(DSAM mutant) or the N-terminal (DN-Term mutant) (Fig 3.17), and co-transfected each 
Fig 3.16 FLAG-Liprin-a1 interacts with GFPLiprin-b1 but not with GFPLiprin-b2 Co-immu-
noprecipitation with anti-GFP antibody from lysates of COS7 cotransfected with FLAG-Liprin-a1 
and either GFP-Liprin-b1  or GFP-Liprin-b2.  Left blot: 100 mg of protein lysates/immunoprecipi-
tation were used. Right blot: aliquots of lysates of transfected cells (10 mg) were used for we-
stern blot. Membranes were blotted with anti-GFP antibody (upper panel) and anti-FLAG antibody 
(lower panel).
Fig 3.15 Endogenous liprin-a1 immunoprecipitates with liprin-b1 in MDA-MB-231 cells. Im-
munoprecipitation with a monoclonal antibody specific for endogenous liprin-a1 from lysates of 
MDA-MB-231 cells. IgG: immunoprecipitation with mouse IgG, negative control. IP: immunopreci-
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mutant with GFP-Liprin-b1 in COS7 cells. As expected, the DN-term mutant was able to 
interact with GFP-Liprin-b1, whereas  the deletion of three SAM domains prevented the 
interaction between the two proteins confirming that the C-terminal region of liprin-a1 
is necessary for the binding with liprin-b1  (Fig 3.18).
Fig 3.18 The C-terminal, but not the N-terminal part of liprin-a1 is required for liprin-a1/
liprin-b1 interaction. Co-immunoprecipitation with anti-GFP antibody from lysates of COS7 cotran-
sfected with GFP-Liprin-b1 and either FLAG-Liprin-a1 full length (F.L.), FLAG-Liprin-a1 DSAM or 
FLAG-Liprin-a1DN-term mutants. Left panel, immunoprecipitation (IP); 300 mg lysates/immunopre-
cipitation were used. Right panel: lysates (LT); 30 mg of lysates were used. The membranes were 
blotted with anti-GFP antibody (upper panels) and anti-FLAG antibody (lower panels).
Fig 3.17 Liprin-a1 mutants used for the biochemical characterization of liprin- a1/liprin-b1 
interaction Scheme of Liprin-a1 mutants generated to characterize liprin-a1/liprin-b1 interaction. 
In ΔSAM1-3 constructs, the red SAM is deleted.
Results
— 75 —
Analysis of the role of liprin proteins in breast cancer cell invasion
Fig 3.19 Deletion of a single SAM domain of liprin-a1 does not affect liprin-a1/liprin-b1 
interaction. Co-immunoprecipitation with antibody anti-GFP from lysates of COS7 cotransfected 
with either GFP (first lane, negative control) or GFPLiprin-b1 and either FLAGLiprin- a1 full len-
gth (F.L.), FLAGLiprin-a1 DSAM1, FLAGLiprin-a1DSAM2, FLAGLiprin-a1DSAM3 or FLAGLi-
prin-a1F3F4. Left panel, immunoprecipitation (IP), 300 mg lysates/immunoprecipitation were 
used; Right panel: lysates (LT), 30 mg of lysates were used.
Fig 3.20 liprin-a1 SAM3 domain alone does not interact with liprin-b1 Co-immunoprecipita-
tion with antibody anti-GFP from lysates of COS7 cotransfected with GFPLiprin- b1 and either 
FLAGLiprin-a1 full length (F.L.), FLAGLiprin-a1F2F3F4 or FLAGLiprin-a1F1. Left panel, immu-
noprecipitation (IP), 300 mg lysates/immunoprecipitation were used. Right panel: lysates (LT), 30 
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To understand the minimal region of liprin-a1 sufficient to mediate the interaction betwe-
en liprin-a1 and liprin-b1, further biochemical analysis were performed. I used FLAG-Li-
prin-a1 mutants generated in the laboratory, lacking a single SAM domain, or the whole 
C-terminal region used as negative control (Fig 3.17, mutants DSAM1, DSAM2, DSAM3 
and F3F4). Each mutant was co-trasfected with GFP-Liprin-b1 in COS7 cells. The resul-
ts of the co-immunoprecipitation experiments showed that the deletion of a single SAM 
domain did not affect the interaction indicating that the binding between liprin-a1 and 
liprin-b1 does not required the three SAM domain together, since the presence of the two 
SAM domain (in all possible combination) is sufficient for binding to liprin-b1 (Fig 3.19). 
To identify the minimal region of interaction between liprin-a1 and liprin-b1, I utilized 
mutants lacking different portions of the C-terminal. The data obtained from this analy-
sis indicated that the deletion of SAM3 of liprin-a1 and a portion of SAM2 (mutant 
F2F3F4) partially inhibited the interaction (Fig 3.20). 
Furthermore, fragment including the only third SAM domain and a small portion of 
SAM2 of liprin-a1 (Fig. 3.17 mutant F1) was not sufficient to mediate the interaction 
with liprin-b1. Taken together, these data indicated that the three SAM domains form an 
organized super-structure that is redundant in some parts but that requires the presence of 
almost two SAMs to allow the interaction between liprin-a1 and liprin-b1. 
3.2.2 Liprin-b1 but not liprin-b2 colocalizes with liprin-a1 at the cell edge.
Previous studies have shown that liprin-b1 co-localizes with liprin-a1 at the plasma 
membrane of COS7 and HeLa cells (Serra-Pages et al., 1998; van der Vaart et al., 2013). 
The subcellular localization of liprin-b2 has been never investigated. In COS7 cells, I 
could observe that endogenous liprin-b1 was enriched at the periphery of the cells and 
co-localized with Erc1a, a liprin-a1 interacting protein, at mature, central focal adhesions 
identified with paxillin (Fig 3.21). Liprin-b1 localized just behind the newly formed focal 
adhesions, as it has been described for liprin-a1 (Asperti et al., 2009) (Fig 3.21 B). 
Endogenous liprin-b2 could not be detected in COS7 cells probably due to the low 
amount of the protein in these cells. I also analyzed the localization of liprin-b1 and 
liprin-b2 in MDA-MB-231 cells, confirming the co-localization between liprin-a1 and 
liprin-b1 at cell periphery (Fig 3.22), while I could not detect endogenous liprin-b2 also 
in these cell line. Therefore, to verify the subcellular localization of liprin-b2, I overex-
pressed GFP-Liprin-b2 in MDA-MB-231 cells and I identified the protein by anti-GFP 
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Fig 3.22 Endogenous liprin-a1 co-localized with liprin-b1 at cell periphery in MDA-MB-231 
cells. (A) Confocal images of MDA-MB-231 cells plated on FN (10  mg/ml) for 1 h, fixed and immu-
nostained for the endogenous liprin- a1 (red) and liprin-b1 (green). Scale, 20 mm. (B) Three-fold 
enlargement of the area indicated by the box in (A).
Fig 3.21 Liprin-b1 colocalizes with Erc1a at the cell periphery. (A) Confocal images of COS7 
cells plated on FN (10  mg/ml) for 1 h, fixed and immunostained for the endogenous liprin-b1 (gre-
en), Erc1a (blue) and paxillin (red). Scale, 20 mm. (B) Plot profile of the signal distribution two focal 
adhesions (FA) obtained with ImageJ plugin RGB profiler.
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antibodies. I co-stained cells for GFP-Liprin-b2, endogenous liprin-a1 and endogenous 
liprin-b1. GFPliprin-b2 did not co-localized with the other two proteins (Fig 3.23A, 3.24). 
On the other hand, the GFP-Liprin-b2 signal revealed puncta in the perinuclear region 
of the cells, partially co-localizing with cortactin, a marker of invadopodia (Fig 3.24B) 
(Weaver, 2008). GFPliprin-b2 puncta seemed to form ring structures, next to cortactin 
positive puncta (Fig 3.24 B). The overexpression of GFPliprin-b1 did not lead to the same 
Fig 3.23 GFPliprin-b2 does not co-localize with liprin-b1 in MDA-MB-231 cells. (A) Confocal 
images of MDA-MB-231 cells transfected with GFPliprin-b2, plated on FN (10  mg/ml) for 1 h, fixed 
and immunostained for (A) GFP(green) and the endogenous liprin-b1 (red). (B) MDA-MB-231 
cells transfected with GFPliprin-b1 and immunostained for GFP (green) and the endogenous 
cortactin.  Scale, 20 mm. 
Fig 3.24 GFPLiprin-b2 partially colocalized with cortactin in MDA-MB-231 cells. (A) Confocal 
images of MDA-MB-231 cells transfected with GFP-Liprin-b2 immunostained for the endogenous 
liprin- a1 (red), GFP (green), and cortactin (blue). Scale, 20 mm. (B) Three-fold enlargement of 
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pattern, thus excluding that the puncta formed by GFPliprin-b2 were artefacts due to the 
overexpression of the protein (Fig 3.23B). 
These findings indicate that the two members of liprin-b subfamily have a different sub-
cellular localization and suggest that could act differently in cell motility.
3.2.3 Liprin-b2	partially	co-localizes	with	cortactin	in	NIH3T3Src	fibroblast	
and its overexpression affects podosomes formation.
Invadopodia are actin-rich protrusions of the plasma membrane into the ECM. The main 
function of these structures is to degrade ECM by the protease accumulation and secretion 
at these structures (Weaver, 2006). Invadopodia were first identified in Src kinase-tras-
Fig 3.25 Liprin-b2 overexpression affects podosome formation in NIH3T3 Src  cells. (A) 
Confocal images of NIH3T3 Src cells transfected with either GFP or GFP-Liprin-b2 immunostai-
ned for GFP (green), cortactin (red) and phalloidin (blue). Scale, 20 mm. (B) Upper panel: three-
fold enlargement of the area indicated by the box in (A). Lower panel: plot profile of the signal 
distribution obtained with ImageJ plugin RGB profiler of a invadopodia indicated by the arrow in 
the upper panel. (C) Quantification of the cells with podosomes (rosette +), without podosomes 
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formed cells, and are thought to constitute the invasive machinery of transformed cells 
(Weaver, 2006). Normal cells such as macrophages and osteoclasts physiologically form 
structures similar to invadopodia, called podosomes, in order to cross and remodel the 
tissues (Linder and Aepfelbacher, 2003).  Podosomes and invadopodia are both charac-
terized by branched actin assembly, the dependence on Src kinase and by the same mo-
lecular components including focal adhesion proteins, integrins and proteases (Buccione 
et al., 2004). Since active Src-trasformed cells form large podosomes, also called rosettes, 
they are commonly used for the study of the invasive machinery of the cells (Murphy and 
Courtneidge). 
My findings from the immunofluorescence analysis of MDA-MB-231 cells indicate that 
liprin-b2 formed ring-like structures localized next to cortactin. To visualize better the 
localization of liprin-b2 with respect to cortactin, I took advantage of  NIH3T3 Src-tras-
formed fibroblasts. I transfected GFPLiprin-b2 in these cells to detect the subcellular 
localization of the protein (Fig 3.25 A-B). The images showed a partial colocalization 
between liprin-b2 and cortactin even though I did not observe the ring structures observed 
in MDA-MB-231 cells (Fig 3.25 B). The plot profile of one representative invadopodia 
showed a co-localization of phalloidin with cortactin as described in literature (Weaver, 
2006) (Fig 3.25 B lower panel). On the other hand, the peaks of signal corresponding to 
liprin-b2 suggested that this protein localized around cortactin.  This suggests that lip-
rin-b2 may be part of the invasive machinery even though it seems not to be a structural 
protein of invadopodia. Furthermore, I noted a reduction in the number of cells forming 
podosomes after transfection with GFP-Liprin-b2 in comparison with the non-transfected 
cells or with cells overexpressing GFP only. 
For quantification, I divided cells in three categories: cells forming podosomes (rosette +, 
Fig 3.25 C), cells without podosomes (rosette -, Fig 3.25 C),  and cells containing no ro-
settes but only actin rich puncta, as described in a previous work (Fig 3.25 C) (Proszynski 
and Sanes, 2013). This analysis shows a reduction in the number of cells forming podo-
somes in NIH3T3 Src transfected with GFP-Liprin-b2 in comparison to cells transfected 
with GFP (Fig 3.24 C). These findings support the hypothesis on the role of liprin-b fam-
ily members on invasion. However, functional analysis is required to demonstrate their 
involvement in this process.
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3.2.4 Liprin-b2 silencing enhances cellular invasion
A recent work from the laboratory of JC Norman has shown that liprin-b2 is involved in 
tumor cell invasion (von Thun et al., 2012). On the contrary, the functional role of lip-
rin-b1 on invasion has never been studied. Therefore, I investigated the invasion ability 
of MDA-MB-231 cells after liprin-b1 or liprin-b2 silencing and  compared the results 
with the effect of liprin-a1 depletion. Specific siRNAs against liprin-a1, liprin-b1 and 
liprin-b2 were transfected in MDA-MB-231 cells (Fig 3.26 A), and then invasion assays 
in vitro were performed (Fig 3.26 B). The results show that liprin-b1 silencing did not 
influence invasion evidently, whereas liprin-b2 depletion led to a significant increase in 
the invasive ability of the cells. This observation is consistent with the published data 
on liprin-b2 (von Thun et al., 2012), and suggest that liprin-b2 has an opposite role on 
invasion in comparison with liprin-a1. Trying to understand whether the silencing of 
liprin-b1 could influence the inhibition of invasion caused by liprin-a1 depletion, I per-
formed double silencing for liprin-a1 and liprin-b1. The results indicated that liprin-b1 
silencing altered not significantly the inhibition of invasion caused by liprin-a1 silencing 
(Fig 3.27). I  also performed double silencing of liprin-a1 and liprin-b2 together to test 
Fig 3.26 Liprin-b2 silencing enhances  invasion in MDA-MB-231 cells (A) MDA-MB-231 cells 
were transfected with siRNAs against either liprin-a1,  liprin-b1 or  liprin-b2 proteins. After 48h 
cells were lysed, loaded on SDS-PAGE and tested by immunoblotting with the indicated anti-
bodies. (B) quantification of invasion after protein silencing with the indicated siRNA. Bars are 
normalized average ± s.e.m. (n=11-15 filters from 6-7 independent experiments). **P<0.005.
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whether liprin-a1 and liprin-b2 could cooperate in the regulation of invasion. Interesting-
ly, the double silencing of liprin-a1 and liprin-b2 led to a further increase of cell invasion 
in comparison to the increase observed in liprin-b2-depleted cells, suggesting a relevant 
role of liprin-b2 in regulating this process by acting independently from liprin-a1 (Fig 
3.27). Further studies are required to clarify the functional link between these two pro-
teins.
3.2.5 Liprin-b2 silencing enhances ECM degradation
Published data from our laboratory indicate that liprin-a1 silencing inhibits ECM degra-
dation, whereas liprin-a1 overexpression increases it (Astro et al., 2011). Following the 
observation that liprin-b1 and liprin-b2 silencing have different effects on cell invasion, 
Fig 3.27 Liprin-b2 silencing enhances the invasion in MDA-MB-231 cells (A) MDA-MB-231 
cells were transfected with siRNAs against either liprin-a1,  liprin-b1, liprin-b2 or in combination 
as indicated. After 48h cells were lysed, loaded on SDS-PAGE and tested by immunoblotting with 
the indicated antibodies. (B) quantification of invasion after protein silencing with indicated siRNA. 
Bars are normalized average ± s.e.m. (n=6-8 filters from 3-4 independent experiments). P values 
were calculated on siRNA luciferase control. **P<0.005.
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I investigated whether liprin-b1 and liprin-b2 depletion might influence the function of 
invadopodia by assessing ECM degradation. The silencing of liprin-a1 was used as pos-
itive control of the experiments. The results showed that liprin-b1 silencing caused a 
reduction of the area of the cells, as seen after liprin-a1 depletion, whereas silencing of 
Fig. 3.28 Liprin-b2 inhibits ECM degradation. (A) MDA-231 cells transfected for 48h with indi-
cated siRNA were replated (50.000 cells per coverslip) for 5 h on Oregon-green 488-conjugated 
gelatin and FN (10 μg/ml). The projected cell areas (B) and the degradation area per cell (C) were 
quantified in control (siRNA luciferase), liprin-a1; liprin-b1 and liprin-b2 depleted cells. The relative 
degraded area (D) was calculated as the ratio between the total degradation area and projected 
cell area. Graphs show normalized  means  ± s.e.m. (n= 51-63 cells per condition, from three 
independent experiments were evaluated) ** P<0.01, *** P<0.001.
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liprin-b2 did not (Fig 3.28 B). Total degrading area was decreased after either liprin-a1 
or liprin-b1 silencing, indicating that liprin-b1 could cooperate with liprin-a1 in regu-
lating ECM degradation (Fig 3.28 C). On the contrary, the depletion of liprin-b2 protein 
led to an increase of ECM degradation, measured both as total degraded area and relative 
degraded area (Fig. 3.28 C-D) The relative degraded area was calculated as the value of 
total degradation area normalized on the projected cell area (Fig 3.28 B,D). The effect of 
liprin-b2 silencing on ECM degradation strengthens the hypothesis of a different role of 
this protein in the regulation of the function of invadopodia in respect to liprin-a1 and 
liprin-b1.
3.2.6 Liprin-b1 and  liprin-b2 silencing have opposite effects on the migration 
of MDA-MB-231 cells.
Liprin-b1functions during migration are unknown, whereas previous work indicated that 
the silencing of liprin-b2 caused a marginal increase in the persistance of migration (von 
Thun et al., 2012). I tested the ability of MDA-MB-231 to migrate after liprin-b1 and 
liprin-b2 silencing. The analysis was performed also in cells transfected with siRNA for 
liprin-a1 as control for the experiment. The 2D random migration assay showed  that the 
Fig. 3.29 Liprin-b1 and liprin-b2 have opposite effects on migration of MDA-MB-231 cells. 
MDA-231 cells were co-transfected with specific siRNAs for luciferase, liprin- a1, liprin-b1 or li-
prin-b2, or with plasmids encoding GFP, as indicated.  Cells were seeded on FN (2.5 μg/ml) for 
time–lapse acquisition. Graphs represent normalized mean values ± s.e.m. of total distance and 
velocity from two independent experiments; n= 35-44 cells. **P<0.01; ***P<0.001.
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silencing of liprin-b1 led to a decrease of the speed and the total distance covered by the 
cells (Fig 3.29). Similar negative effects on migration were observed after silencing of 
liprin-a1 (Astro et al, 2011). On the contrary, preliminary results indicate that liprin-b2 
silencing  did not affect cell motility (Fig 3.29). These data support the hypothesis of the 
cooperation between liprin-a1 and liprin-b1 in regulating cell motility, while they indi-
cate that liprin-b2 acts as an antagonist in this process. 
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4 DISCUSSION AND CONCLUDING REMARKS
4.1 Discussion
Liprin-a1 is a cytosolic scaffold protein involved in the regulation of cell adhesion and 
migration (Asperti et al., 2009; Asperti et al., 2010). Acting as a scaffold, liprin-a1 in-
teracts with several partners, that mediate its function in the regulation of lamellipodia 
stability, focal adhesion turnover, membrane recycling and remodelling the actin cytoske-
leton. Moreover, the gene PPFIA1, coding for liprin-a1, has been found amplified in hu-
man cancers. Consistently with this observation, a study from our laboratory in collabora-
tion with the anatomo-pathology unit at San Raffaele Scientific Institute, has revealed that 
liprin-a1 protein levels are increased in about the 50% of human breast cancer samples 
analyzed by immunohistochemistry (Astro et al., 2011). Another study from our labora-
tory has demonstrated that liprin-a1 cooperate with ERC1a and LL5 proteins to regulate 
tumor cell motility in vitro (Astro et al., 2014). Indeed, the silencing of liprin-a1 in the 
invasive breast cancer cell line MDA-MB-231 causes an increase of lamellipodia. This 
results in a reduction of cell migration on FN and invasion through Matrigel. Conversely, 
the overexpression of liprin-a1 leads to the formation of more stable lamellipodia in com-
parison with the lamellipodia formed by control cells, resulting in increased cell motility. 
Starting from these interesting results, during my PhD I have investigated the role of 
liprin-a1 in vivo. I have tried to understand whether the effects of liprin-a1 overexpres-
sion/silencing observed in vitro were mirrored by an altered ability of the tumor cells to 
invade tissues and give rise metastases in mice. Further studies on mechanisms of action 
of liprin-a1, have shown that liprin-a1 interactors can mediate its functions in cell mo-
tility. Indeed, LAR and GITs proteins, two direct interactors of liprin-a1, cooperate with 
liprin-a1 in the regulation on cell spreading (Astro et al., 2011). It has been also shown 
that the liprin-a1 binding protein ERC1a, and the ERC1a-associated proteins LL5, coo-
perate with liprin-a1 in the regulation of tumor cell migration and invasion. A model has 
been proposed, in which liprin-a1, ERC1a and LL5 proteins are recruited to the plasma 
membrane of migrating cells by localizing close to the adhesion sites of active protrusion. 
The results suggest that the complex may regulate the stability of lamellipodia and cell 
adhesion turnover by influencing integrin internalization and as a consequence, cell moti-
lity (Astro et al., 2014). In order to better understand the mechanisms by which liprin-a1 
influences tumor cell motility, the secondary aim of my PhD work, I have addressed the 
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role of other liprin-a1-binding proteins: the members of the liprin b-subfamily, liprin-b1 
and liprin-b2. Few data are available about the role of liprin-b1 and liprin-b2 in cell mi-
gration and invasion. It has been described that liprin-b1 belongs to a complex including 
liprin-a1, ERC1a and LL5 proteins, even if its function remains unclear (Van der Vaart 
et al., 2013). Liprin-b2 is considered a potential interactor of liprin-a1, based on its se-
quence similarity with liprin-b1, althogh a direct interaction has not been demonstrated 
yet. Some observations indicate that liprin-b2 affects cellular migration and invasion (von 
Thun et al., 2012). However, further studies are needed to clarify the physical and functio-
nal relationship between liprin-a1 and liprin-b2. 
4.1.1 Role of liprin-a1 in vivo
Focusing on the first part of the project I used the highly invasive breast cancer MDA-
MB-231 cells to generate cell lines with either stable overexpression or silencing of li-
prin-a1. As expected, the characterization in vitro confirmed what has been previously 
observed after transient transfection of either GFPLiprin-a1 or liprin-a1 siRNA, respecti-
vely. Cells overexpressing liprin-a1 showed a lower number of lamellipodia generated 
per time unit, but an increase of lamellipodia persistence with respect to control cells. 
This led to an increased speed of migration on in comparison with the control cells. Fur-
thermore, liprin-a1 overexpression led to an increased invasion ability through Matrigel. 
Conversely, it did not affect cell viability and proliferation. Liprin-a1-depleted cell lines 
showed a significant reduction in the invasion ability through Matrigel, while viability 
and proliferation rate were similar to the control cells. In order to investigate the effect of 
liprin-a1 overexpression or silencing on the invasion in vivo, two different assays were 
performed: experimental metastasis and spontaneous metastasis assays. The first consists 
in the injection of tumor cells in the lateral tail vein of the animals. This assay gives in-
formation about the extravasation ability of the cells and their ability to colonize distant 
organs and give rise to metastases (M.M Richert et al., 2005). The spontaneous metastasis 
assay consists either in a orthotopic or subcutaneous transplantation of tumor cells that 
generate a primary tumor and eventually metastatize at distant sites. This assay mimics 
human cancer growth and the process of metastasis formation. It gives information not 
only about the later stages of metastasis formation, as in the experimental metastasis as-
say, but also about the tumorigenic capacity of the cells transplanted, and the ability of 
the cells to detach from the primary tumor and to invade the surrounding ECM. However, 
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the two techniques are considered complementary in the literature. At the end of both 
assays I analyzed the formation of pulmonary metastases, since the injection in the lateral 
tail vein is expected to give rise metastases in the lungs. Moreover, MDA-MB-231 cells 
are described to give rise pulmonary metastases after orthotopic transplantation (Xue B. 
et al., 2013). I used female athymic nude mice for experimental metastasis assay, and 
NSG (NOD scid IL2rgnull) mice for spontaneous metastasis assay as described in literature 
(Iorns et al., 2012). After orthotopic transplantation, tumor cell growth was monitored. I 
could observe that tumors originating from liprin-a1 overexpressing cells had a prolife-
ration rate similar to the tumors originated by control cells. This suggests that liprin-a1 
does not have a role in tumor growth. Surprisingly, both the injection and the transplan-
tation of liprin-a1 overexpressing cells did not result in an increase of lung colonization 
in in comparison with controls. The results obtained could be explained considering that 
MDA-MB-231 cells are highly invasive per se, thus the potentiated lung colonization 
due to the liprin-a1 overexpression may be underscore under the experimental conditions 
used. The injection of liprin-a1-depleted cells has been more informative. As hypothesi-
zed, the intravein injection of liprin-a1-depleted cells resulted in a decrease of lung colo-
nization in comparison with the lung colonization observed in mice injected with control 
cells. These data suggest that the silencing of liprin-a1 affects cells extravasation, possi-
bly because of the instability of lamellipodia and the consequent defect in cell motility. 
I excluded a defect in cell proliferation because proliferation and survival of the clones 
were comparable with the control ones. The transplantation of liprin-a1-depleted cells 
gave rise to tumors comparable with the control ones for volume and weitgh. Because of 
this, it may be hypothesized that liprin-a1 is not involved in the growth of primary tumor. 
Furthermore, I analysed liprin-a1 protein levels in primary tumors. Both western blot 
analysis and immunofluorescence indicated that the silencing of the protein was maintai-
ned during the tumor growth and the formation of metastases. The analysis of lung co-
lonization confirmed the result obtained in the experimental metastasis assay. However, 
in spontaneous metastasis assay the reduction in lung colonization by liprin-a1-depleted 
cells was stronger than in experimental metastasis assay. This suggests that liprin-a1 
silencing may affect not only the extravasation, but also the detachment of cells from 
the primary tumor and the invasion of the surrounding ECM. The data obtained with the 
spontaneous metastasis assay indicate that the altered migration observed in the functio-
nal assays in vitro is reflected by defects in different steps of tumor cell invasiveness in 
vivo. This is the first observation that supports a role of liprin-a1 in invasiveness in vivo.
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4.1.2 Role of liprin-b proteins in tumor cell motility
In order to address the involvement of both liprin-b1 and liprin-b2 in liprin-a1-mediated 
cell motility, I used COS7 cells for biochemical analysis and MDA-MB-231 cells for 
functional assays. Initially I confirmed the physical interaction between liprin-a1 and 
liprin-b1. This binding has been previously detected by interaction trap assay in COS7 
cells (Serra Pages et al., 1998) and by immunoprecipitation and GST-pull down in HeLa 
cells (van der Vaart et al., 2013). I detected the binding also in MDA-MB-231 cells, by 
immunoprecipitating either the endogenous or the overexpressed proteins. This is the first 
evidence of the interaction between liprin-a1 and liprin-b1 in a breast cancer cell line. I 
performed further immunoprecipitation experiments to identify the region that mediates 
the link between the two proteins. Interaction trap assays have shown that the binding is 
mediated by the SAM domains of  the two proteins (Serra Pages et., 1998). I co-expressed 
in COS7 cells GFP-Liprin-b1 and FLAG-Liprin-a1 mutants lacking either the C-termi-
nal or the N-terminal portion. Immunoprecipitation confirmed that GFP-Liprin-b1 inte-
racted with both FLAG-Liprin-a1 full length and the C-terminus of FLAG-Liprin-a1. As 
expected, the lack of the C-terminal region in FLAG-Liprin-a1 prevented the binding. In-
terestingly, the immunoprecipitation of FLAG-Liprin-a1 mutants lacking only one of the 
three SAM domains indicated that this deletion was not sufficient to prevent the binding 
with GFP-Liprin-b1. This indicates that the interaction between liprin-a1 and liprin-b1 
does not require all three SAM domains. In fact, the presence of two SAM domains (in 
every possible combination) in liprin-a1 is sufficient for binding to liprin-b1. The dele-
tion of SAM3 and a portion of SAM2 did not prevent the binding. On the other hand, the 
mutant including the isolated SAM3 and a small portion of SAM2 did not interact with 
GFP-Liprin-b1. These observations partially agree with crystallographic studies. Indeed, 
a crystallographic study indicates that the SAM domains are positioned in tandem with 
a head to tail interaction and that the head face of SAM1 in liprin-a1 mediates the inte-
raction with the tail of SAM3 of liprin-b (Fig 4.1 C) (Wei et al., 2011). Another study pro-
poses two different models for the interaction between liprin-a1 and liprin-b1. In the first 
model, liprin-a1 and liprin-b1 associate to create a “closed dimer”, that is mediated by 
the interaction between the SAM3 domains of a single dimer of liprin-a with the SAM3 
domains of a single dimer of liprin-b proteins (Fig 4.1 A). A second model proposes the 
formation of an “open scaffold”, in which the SAM3 domain of both a and b molecules 
interacts with more than one dimer (Fig 4.1 B) (Stafford et al., 2011). These two studies 
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propose either SAM1 or SAM3 as mediator of interaction but do not clearly identify the 
SAM domain involved (Fig 4.1). However, they hypothesized that SAM domains are 
folded in a structure that acts as a structural and functional supramodule not described 
before for SAM domains. My findings are consistent with the hypothesis of a supra-mo-
dule, even though I observed that SAM3 alone is not sufficient to mediate the interaction 
between liprin-a1 and liprin-b1 and also the deletion of SAM1 does not prevent the bin-
ding. I would like to speculate that the region connecting the SAM may have a role in me-
diating the interaction, since in the single SAM-deleted mutants the connecting regions 
were conserved. One possibility is that the SAM domains form a structure with some 
redundant regions that can compensate the deletion of other portions in vivo. According to 
this hypothesis two SAM domains and the connecting regions of liprin-a1 are sufficient 
to mediate the formation of liprin-a/b heterodimers. However, further analysis required 
to test this hypothesis. No interaction could be detected between FLAG-Liprin-a1 and 
GFP-Liprin-b2 by immunoprecipitation. This suggests that liprin-b1 and liprin-b2 may 
have different partners and possibly different subcellular localization. This hypothesis 
was confirmed by immunofluorescent experiments. Endogenous liprin-b1 colocalizes at 
the cell edge with liprin-a1 and ERC1a, a liprin-a1-binding partner, while endogenous 
Fig 4.1 Models of interaction between liprin-a and liprin-b proteins. (A) The “closed dimer” 
model of interaction between liprin-a1 and liprin-b2 molecules. The three tandem SAM domains 
of liprin-as interact with liprin-bs (B) An alternative “open scaffold” model is shown in which mul-
tiple a- and b-liprins stack indefinitely. In both “closed dimer” and “open scaffold” models the coi-
led-coil domains are predicted to radiate from the central interacting SAM domains. Adapted from 
Stafford et al., 2011  (C) Alternative model of interaction between liprin-a and liprin-b: the SAM1 
of liprin-a interacts with the SAM3 of liprin-b protein. Adapted by Wei et al., 2011.
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liprin-b2 was not detected in MDA-MB-231cells, possibly due to the low levels of the 
protein in this cell line. In order to overcome this limitation, GFP-Liprin-b2 was ove-
rexpressed in MDA-MB-231 cells and then detected by an anti-GFP antibody.
GFP-Liprin-b2 signal revealed puncta in the perinuclear region of MDA-MB-231 cel-
ls, where invadopodia localize (Weaver et al., 2008). Overexpression of GFP-Liprin-b1 
did not shown this type of distribution. Co-staining for cortactin, a marker of invado-
podia, showed that GFP-Liprin-b2 and cortactin formed a ring-like structure. This fin-
dings suggests a potential involvement of liprin-b2 in the formation of invadopodia. I 
also observed that the overexpression of GFP-Liprin-b2 in Src-transformed NIH3T3 cel-
ls negatively affected the percentage in the number of cells forming podosomes. Src is 
a key regulator of podosomes formation and Src trasformed cells are a cellular model 
commonly used for the study of invadopodia. In NIH3T3-Src cells, the overexpression of 
GFP-Liprin-b2 caused a reduction in the number of cells forming podosomes suggesting 
that liprin-b2 is implicated in their formation. To address the involvement of liprin-b1 
and liprin-b2 in cell invasion and migration, I tested the effect of the silencing of either 
protein in specific assays. Random migration on FN was reduced after the depletion of 
liprin-b1, whereas silencing of liprin-b2 caused a weak increase of cell speed, although 
not statistically significant. From this analysis I speculate that liprinb1 cooperates with 
liprin-a1 in the control of cell migration, whereas liprin-b2 may act by influencing cell 
motility by a different, liprin-a1-independent mechanims. Analysis of invasion through 
Matrigel supports this hypothesis. Liprin-b1 silencing did not affect cell invasiveness, 
whereas liprin-b2 depletion led to an increase of invasion. Moreover, the silencing of 
both liprin-a1 and liprin-b2 together, led to a stronger increase of invasion. This suggests 
that liprin-a1 and liprin-b2 act in different pathways. Indeed, if they acted in the same 
pathway, the depletion of liprin-a1 are expected to revert the increase in invasion caused 
by liprin-b2 silencing. Finally, analysis on ECM degradation confirmed that liprin-b2 
depletion promoted it whereas the silencing of liprin-b1 affected only the total degraded 
area. This strenghtens the hypothesis of the involvement of liprin-b2 in a mechanism 
controlling tumor cell invasiveness.
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4.2 Concluding remarks
My findings indicate that liprin-a1 has a functional role in tumor cell invasion in vivo. 
This is the first evidence of the involvement of liprin-a1 in the metastatic process in 
mice. I have hypothesized that this effect could be caused by the action of liprin-a1 on 
lamellipodia dynamics. However, future imaging studies are needed to shed light on the 
behaviour of liprin-a1-depleted cells during tumorigenesis and metastatization. Moreo-
ver, further analysis on human breast cancer samples are required, to understand whether 
liprin-a1 may be considered a predictive marker of particular subpopulations of human 
breast tumors. The findings of my work open also interesting questions about the invol-
vement of liprin-b2 in the formation of invadopodia and about the unknown binding 
partners that could mediate the anti-invasive function of this protein. 
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5 MATHERIALS AND METHODS
5.1 Antibodies and materials
Polyclonal antibody (pAb) anti-Liprin-β1 and anti-Liprin-b2 were from Sigma-Aldrich 
(St. Louis, MO, U.S.A.). The anti paxillin was from BD Biosciences (San Jose, CA, 
U.S.A.). The pAb against GFP was from Life Technologies (Paisley, Scotland, U.K.). 
The anti-liprin-a1 pAb was raised against the human glutathione-S-transferase (Knight 
et al)-liprin-a1 (818-1202) fusion protein prepared from bacteria transformed with the 
pGEX-Liprin- a 1(818-1202) construct as described (Asperti et al, 2009). Rabbits were 
immunized with the GSTliprin-a1(818-1202) by Eurogentec (Seraing, Belgium). Affi-
nity purification of antiliprin-a1 si1554 serum was performed by Simona Paris in the 
laboratory by using the p-MAL Protein Fusion and Purification System from New En-
gland Biolabs (Ipswich, MA,U.S.A.). Anti-liprin-a1 pAb commercially available form 
Protein Tech (Chicago, IL, U.S.A). The monoclonal anti liprin-α1 was from Santa Cruz 
Biotechnology (Santa Cruz, CA, U.S.A.)  The polyclonal rabbit anti liprin-α1 and chi-
cken anti-GFP antibodies were from Abcam (Cambridge, U.K.). Fluorescein isothiocya-
nate- (FITC) and cyanine 5 (CY5)-conjugated anti-rabbit, anti-mouse and anti-chicken 
secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, 
PA, U.S.A.), FITC- and TRITCconjugated phalloidin were from Sigma-Aldrich. Oregon 
488-gelatin, Alexa-488, Alexa-568 and Alexa-546 anti-rabbit, anti-rat, anti-mouse and 
anti-hamster secondary antibodies were from Life Technologies. Fibronectin (FN) and 
matrigel were from BD Biosciences. EGF from Peprotech (Rocky Hill, NJ, U.S.A). Bo-
vine serum albumin 138 (BSA) was from Roche. Peroxidase-conjugated anti-rabbit and 
anti-mouse antibodies, and the Enhanced Chemiluminescence (ECL) Detection System, 
were from Amersham Biosciences (Little Chalfont, U.K.). Peroxidase-conjugated an-
ti-goat antibody was from Southern Biotech (Birmingham, AL, U.S.A); the anti-hamster 
was from Thermo Scientific (Waltham, MA, U.S.A). Bradford protein assay reagent was 
from BIO-RAD (Munich, Germany).
5.2 DNA constructs
The full length pFLAG-Liprin-a1 and pEGFP-Liprin-a1 (full length human liprin-α1) 
were described previously (Totaro et al, 2007). Fragments F1 including amino acids (aa) 
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1009-1202, F2 (aa 676-1009), F3 (aa 375-675) and F4 (aa 1-346) of human liprin-α1 were 
obtained by reverse transcriptase (RT)-PCR performed starting from mRNA isolated 
from SKNBE human neuroblastoma cells. The final constructs were assembled and sub-
cloned to obtain the pFLAG-Liprin-F1, pFLAG-Liprin-F2F3 and pFLAG-Liprin-F2F3F4 
plasmids. pFLAG-Liprin-ΔSAM1, pFLAG-Liprin-ΔSAM2 and pFLAG-Liprin-ΔSAM3 
plasmids were produced by PCR performed starting from FLAG-Liprin-α1 plasmids 
and then were assembled and subcloned to obtain the final constructs.The construct 
pFLAG-Liprin-a1 DN-terminal and pFLAG-Liprin-a1 DC-terminal were produced by 
PCR performed starting from pFLAG-Liprin-a1 plasmids and then were assembled and 
subcloned to obtain the final constructs. pEGFP-C1 plasmids were from Clontech Labo-
ratories (MountainView, CA, U.S.A.). 
The constructs GFP-Liprinb1 and GFP-Liprinb2 were from Dr. Casper C. Hoogenraad 
(Spangler et al., 2011).
5.2.1 Small Interfering RNA (siRNA) ans Short hairpin RNA (shRNA)
Two siRNAs were used for human liprin-a1, liprin-1a and liprin1b, targeting the
sequences 5’-CCAAGGTACAAACTCTTAA-3’ and 5’-
CGAGGTTGGTCATGAAAGA-3’ of liprin-α1 respectively. The siRNA were purchased 
from Life Technologies and Qiagen, respectively. Starting from the sequence of the two 
siRNAs, two shRNAs were designed according to the manifacture protocol of pSuper Vec-
tor  (Oligoengine, Seattle, WA). The oligo obtained were cloned into the pSuperVector 
GFP.neo (Oligoengine, Seattle, WA), according to the manufacturer protocol. The plasmid 
obtained were named shRNA1, deriving from the sequence of siRNA liprin-a1a and shR-
siRNA Sequence (5’-3’)
Sense Antisense
Luciferase [CAU CAC GUA CGC GGA AUA C] RNA –
[TT]DNA




[CCA AGG UAC AAA CUC UUA A] RNA –
[TT]DNA




[CGA GGU UGG UCA UGA AAG A] RNA –
[TT]DNA




[GAU GAG UGA UGC AAG UGA CAU GUU 
G] RNA 




[CAA CCA CAG GGU GAU GGA GUG GUU 
A] RNA
[UAA CCA CUC CAU CAC CCU GUG 
GUU G] RNA
Table 5.1 Scheme of the siRNA sequence used in this work.
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NA2, deriving from the sequence of siRNA liprin-a1b. The siRNAs used against liprin-b1 
and liprin-b2 were stealth RNAi siRNA and target the following sequence: 5’-GATGA-
GTGATGCAAGTGACATGTTG-3’ for liprin-b1 and 5’- CAACCACAGGGT GATGGAGTG-
GTTA-3’ for liprin-b2. They were purchased from Life Technologies (Paisley, Scotland, 
U.K.).  A siRNA specific for luciferase, used as negative, targeting the sequence 5’-CA-
TCACGTACGCGGAATAC-3’ was purchased from Life Technologies. All siRNAs were 
trasfected using LipofectamineTM 2000 (Life Technologies) with 50 nM siRNA in se-
rum-free medium. After trasfection, cells were incubated in growth medium for 48 hours, 
and then used for biochemical and functional assays. All siRNAs could efficiently down-re-
gulate the endogenous proteins in COS7 cells and/or human cancer cells MDA-MB-231. 
5.3 Cell culture
5.3.1 Cell lines
COS7 cells were cultured in DMEM containing 10% FetalClone® III (Hyclone), 100
U/ml penicillin, 100 mg/ml streptomycin, 20 mM glutamine. 
MDA-MB-231, was growth in DMEM/F12 1:1, containing 10% FBS (Euroclone, Wether-
by,U.K.), 100 U/ml penicillin, 100 mg/ml streptomycin, 20 mM glutamine.
NIH-3T3 cells were cultured in DMEM containing 10% FBS, 100 U/ml penicillin, 100 
mg/ml streptomycin, 20 mM glutamine. Cell lines up to the 9-10th passage after thawing 
were used for the experiments.
5.3.2 Generation of stable transfected cell lines
Independent cell lines stably expressing either GFP-Liprin-a1, GFP, ShRNA1, shRNA2, 
or pSuper vector GFP were obtained after transfection of MDA-MB-231 cells with 2 μg 
either of GFP-Liprin-α1, GFP, ShRNA1, ShRNA2, or pSuper vector GFP, respectively. 
Clones resistant to selection with 1 mg/ml of G418 (Merck Millipore) were expanded 
from single cells isolated by limiting dilution.
5.3.3 Viability and proliferation assay
Cell viability was assessed by a colorimetric assay based on the reduction of MTT 
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[3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide]. Cells were treated at 
37°C for 1 hour with 0.5 mg/ml MTT (Sigma-Aldrich, St. Louis, MO, U.S.A.), added to 
the medium. After removal of the medium with MTT, DMSO was added and absorbance 
of the purple product was measured at 570 nm (Sunrise™, Tecan Group Limited). For 
cell proliferation, 2,000 cells were seeded in 24-well plates and their growth evaluated by 
counting in Burker chamber every 24 hours.
5.4 Trasfections
5.4.1 Lipofectamine
All the cell lines seeded in 3, 6 or 10 cm diameter plates or (6 to 24) well dishes were
trasfected with Lipofectamine-2000® (Invitrogen Ltd) for biochemistry or immunofluo-
rescence microscopy, respectively. For biochemistry 60-mm diameter plates, 2-4 μg of 
DNA and 10 μl of Lipofectamine-2000® were diluted separately in
300 μl of Optimem® (Gibco). In the case of 10 cm diameter plates 8 μg of DNA and 25μl 
of Lipofectamine-2000® were used, each diluted in 500 μl of Optimem®. For
immunofluorescence, trasfection of siRNAs, DNA or co-trasfection of both, was perfor-
med in 6-well plates or 6 cm dishes with Lipofectamine-2000®. The procedure
was similar to what previously described for DNA trasfection. SiRNA and/or DNA at
the final concentration of 50-100 nM and 2-4 μg DNA respectively, were diluted in 250μl 
of Optimem®, and 5 μl of Lipofectamine-2000® were diluted separately in 250 μl of 
Optimem®. DNA solutions were added drop by drop to Lipofectamine-2000® solution, 
and incubated 20 min at RT before being added to the cells in Optimem®. After 4-5 hours 
Optimem® was replaced with complete medium. Cells were processed after 18-48 hours, 
as indicated.
5.5	 Immunofluorescence
Cells grown on 10 μg/ml FN (BD Biosciences) coated glass coverslips (BDH
Chemicals, Poole, UK), were fixed for 15 min at RT in 3% paraformaldehyde in PBS.
After two washes with PBS, paraformaldehyde was blocked by 10 min incubation with 
50 mM NH4Cl. After two washes with PBS, cells were permeabilized with 0.1-0.05% 
Triton X-100 in PBS for 4 min, washed twice with PBS, and incubated 10 min with 0.2% 
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gelatine from MERCK (Whitehouse Station, NJ, USA) in PBS. Coverslips were then in-
cubated for 60-120 min at RT or overnight at 4° C with primary antibodies diluted in 0.2% 
gelatine in PBS. After two washes with 0.2% gelatine in PBS, the samples were incubated 
for 45 min with secondary antibodies. All coverslips were mounted with 1 drop of Gelva-
tol (20% polyvinyl alcohol, 2% propylgallate, in PBS), glycerol solution (glycerol 70% 
in PBS plus 0.01% phenylethilendiammine) or ProLong® Gold Antifade Reagent (Life 
Technologies) and observed either at epifluorescence or confocal microscopes.
5.6 Biochemical analysis
5.6.1 Preparation of lysates
Cells grown in 60 or 100 mm dishes were transferred on ice, washed twice with 10
ml of ice-cold TBS (20 mM Tris-HCl, pH 7.5, 150 mM NaCl), and solubilised with
150- 250 μl of lysis buffer [0.5% Triton X-100, 150 mM NaCl, 20 mM Tris-Cl; pH 7.5,2 
mM MgCl2, 1 mM sodium orthovanadate, 10 mM sodium fluoride, and anti-proteases 1x 
Complete® (Roche (Manheim, Germany)]. Lysates were transferred to tubes and rotated 
for 15 min by end-over-end mixing at 4°C. The insoluble material was removed by cen-
trifugation at 12000g at 4° C for 15 min. Protein determination was done using Bradford 
protein assay reagent from BIO-RAD (Hercules, CA, U.S.A.).
5.6.2 Immunoprecipitation
Primary antibodies pre-adsorbed for 1 hour to 25 μl of protein A Sepharose beads (Amer-
sham Biosciences) were added to lysates (2 mg protein/ immunoprecipitation), and incu-
bated for 3 h at 4°C with rotation. Immunoprecipitates were washed four times with 0.5 
ml of lysis buffer with 0.1% Triton X-100.
5.6.3 SDS-PAGE and western blot analysis
Immunoprecipitates, lysates and unbound fractions were subjected to sodium dodecyl sul-
fate (SDS)-polyacrylamide gel electrophoresis (PAGE) (Laemmli, 1970). Proteins from 
gels were electrophoretically transferred to 0.2 μm PROTRAN® nitrocellulose membra-
nes (Schleicher & Schuell BioScience GmbH, Dassel, Germany), and stained with 0.2% 
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Ponceau in 3% TCA to visualise molecular weight (MW) standards and proteins. Filters 
were blocked for 1 hour at RT with 5% non-fat dry milk or 5% BSA (Durocher et al) in 
50 mM Tris-HCl, 150 mM NaCl (pH 7.5), and then incubated for 2 h in the same buffer 
containing the diluted primary antibodies. For the detection of primary antibodies, blots 
were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies and 
revealed by ECL system (Amersham Biosciences).
5.6.4	 Quantifications	of	protein	levels
Densitometric analysis of blots was performed using the ImageQuant® software from 
Molecular Dynamics Inc. (Sunnyvale, CA) on images acquired with a Molecula Dynami-
cs Personal SI Laser Densitometer (Amersham Biosciences). Each value was
normalized to the protein levels of an internal standard in the same lysate (β-tubulin).
5.6.5 Stripping and reprobing
Filters were sometimes subjected to stripping and reprobing. Briefly, they were incubated 
in a large volume of stripping buffer (100 mM β-mercaptoethanol, 2% SDS,62.5 mM 
Tris-HCl, pH 6.8) at 50° C for 30 min with gentle mixing. Filters were then washed twi-
ce for 10 min with 50 mM Tris-HCl, 150 mM NaCl (pH 7.5) supplemented with 0.5 % 
Tween-20. After stripping, filters were either quickly washed in the absence of detergent 
and stored at 4° C, or directly reprobed as described above. Alternatively, filters were 
subjected to ‘mild’ acid stripping. Briefly, filters were incubated in stripping solution (0,2 
M glycine, 0,1% SDS, 1% Tween-20) set to pH 2.2, with gentle mixing for 10 minute 
at room temperature. Filters were then washed twice for 5 min in PBS, followed by 2 
washes of 5 min each with 0.5 % Tween-20, 50 mM Tris-HCl, 150 mM NaCl (pH 7.5).
5.7 Microscope techniques
5.7.1	 Wide-field	and	confocal	analysis
Samples were observed using a Zeiss Axiovert 135 TV with QImaging Exi-Blue (Oberko-
chen, Germany) equipped with a Hamamatsu CCD Orca II camera from Hamamatsu Pho-
tonics K.K. (Hamamatsu, Japan). An Olympus IX70 microscope (Olympus, Tokyo, Japan) 
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was used to measure degradation, projected cell areas and number of cortactin-, filamentous 
actin-positive invadopodia. Confocal microscopy of biological samples was performed on 
the laser scanning confocal Ultraviewers from Perkinelmer (Waltham, MA, U.S.A.). For 
multichannel imaging, fluorescent dyes were imaged sequentially in frame or line-inter-
lace mode to eliminate cross-talk between different channels. FITC and Alexa-488 were 
excited with a 488-nm ArKr laser line. TRITC and Alexa-568 were excited with a 543-nm 
HeNe laser line; CY5 was excited with a 633-nm HeNe laser line. Images were processed 
using Adobe Photoshop® CS4 from Adobe Systems Incorporated (Seattle, WA, U.S.A.), 
and analysed using the public domain NIH Image software (ImageJ).
5.7.2	 Time-lapse	wide-field	microscopy
To observe movement of living cells in real time during 2D random migration, MDA-
MB-231 cells were cultured for 1 day before trasfection with DNA and/or siRNAs. After 
24-48 hrs cells were collected, washed with complete medium and plated on 6 well plates 
pre-coated with 2,5 μg/ml of FN. Images were acquired using a Zeiss Axiovert S100 TV2 
microscope (Oberkochen, Germany) equipped with a Hamamatsu Orca II CCD digital 
camera from Hamamatsu Photonics K.K. (Hamamatsu, Japan), and a Cage Incubator de-
signed to maintain all the required environmental conditions for cell culture, which was 
driven by an Oko-Vision software (OkoLab, Naples, Italy).
5.8 Morphological analysis 
5.8.1	 Measurement	of	the	area	of	ECM	degraded	by	MDA-231	cells	on	fluo-
rescent gelatin 
MDA-MB-231 cells were trasfected for 1 day with either Flag-βgalactosidase or Flag-Lip-
rin-α1, or cotrasfected for 2 days with p-EGFP-C1 and small interfering RNAs (siRNAs). 
After 18 h on FN (10 μg/ml) cells were fixed with 3% PFA and subjected to immunoflu-
orescence. For quantification, images were first subjected to adjustments using ImageJ 
software to remove diffuse background fluorescence. The area of degradation per cell 
was analyzed using ImageJ by performing a threshold of the green channel (488 nm) to 
create a binary image in which the total dark area corresponding to degraded gelatin was 
measured. (Clark et al, 2007). The measurement of the total cell area was evaluated on 
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thresholded images, by measuring the total area occupied by the whole cells. Data were 
pooled from 3 independent experiments in which a total of 60 cells were analyzed. Statis-
tically significant differences were evaluated by the Student’s t-test. Value of P<0.05(*) 
were considered statistically significant.
5.8.2	 Quantification	of	migration	and	of	lamellipodia	protrusion
MDA-231 cells cotrasfected with p-EGFP-C1 and siRNAs were plated on FN-coated 
6-well plates (2D migration) or on the top of NIH-3T3 derived-matrix (3D migration) and 
subjected to time-lapse acquisition with an Axiovert microscope (Zeiss). Images
were captured with 10x or 20x lens at 5-min intervals for 5 h, or at 6-min intervals for 8 h, 
respectively. Migration paths were calculated from the nuclear positions of cells obtained 
from 4 fields per well using two plugins available for ImageJ software (Manual tracking 
and Chemotaxis tool). The track of each cell was used to measure different parameters of 
migration: total (cell path) and Euclidean distances (length of the line segment, calculated 
between the start and the end point of the cell trajectory),
cell velocity and directionality. This parameter is an index of the persistence of the cell 
movement, given by the ratio between the Euclidean and the total distances. This val-
ue may change between 0 and 1, where 1 corresponds to the maximum linearity of the 
trajectory. Cells undergoing division and non-moving cells were ignored in this analy-
sis (Rhoads & Guan, 2007). At least 50 cells from several experiments were recorded 
for each condition. To quantify lamellipodia dynamics, for each condition I analyzed 
10 moving cells (90-100 lamellipodia) from two independent experiments. Images were 
quantified with ImageJ, by counting the number of lamellipodia forming during 1 or 5 
h. The persistence of each protrusion was evaluated by considering the amount of time 
elapsed between the formation of lamellipodium and its disassembly. Statistically signif-
icant differences were analysed by the Student’s t- test.
5.8.3 Fluorescent-gelatin degradation assay
For gelatin degradation assay, MDA-231 cells trasfected for 24-48 h were replated for 5 
h (5x104 cells) on Oregon-green 488-conjugated gelatin (Life Technologies) and 10 μg/
ml FN pre-coated coverslips. Cells were then fixed with 3% PFA, stained with appro-
priate primary and secondary antibodies or fluorescent phalloidin, and observed with an 
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Olympus IX70 microscope (Olympus, Tokyo, Japan). ImageJ software was used to mea-
sure degradation (dark spots on fluorescent gelatin bright areas), projected cell areas, and 
number of active invadopodia (cortactin-, filamentous actin-positive dots that localized 
with areas of gelatin degradation.) (Clark et al., 2007).
5.9 Functional analysis
5.9.1 Migration assay 
5.9.1.1 Two-dimensional (2D) random migration assay
For 2D random migration, MDA-231 trasfected cells for 48 h were seeded (5x104cells/
well) on 2.5 μg/ml FN pre-coated six well plates, and allowed to attach at
37°C for 3 h before time-lapse with an Axiovert microscope (Zeiss). Time lapse was per-
formed for the following 5 hours. Images were captured at 5-min intervals using a CCD 
video camera (Orca II, Hamamatsu) with OKO Vision software. For each cell population, 
accumulated (cell path) and euclidean distances (cell displacement), mean velocity and 
directionality (persistence= path/displ) were calculated during 5 h assay with Manual 
tracking and Chemotaxis Tool of ImageJ (National Institute of Health, Bethesda, MD, 
USA). Cells undergoing division and non-moving cells were ignored.
5.9.1.2	 Three-Dimensional	(3D)	fibrillar	cell	migration
For 3D cell migration, 5x105 MDA-231 trasfected cells were seeded on the top of
NIH-3T3 fibroblast derived ECM for 6 h at 37°C, before live imaging acquisition with 
an Axiovert microscope (Zeiss). Images were captured at 6-min intervals for 8 h, using 
the CCD video cameras (Orca II, Hamamatsu). Different parameters were evaluated and 
quantified with ImageJ: accumulated (cell path) and euclidean distances (cell displace-
ment), mean velocity and directionality (persistence= path/displ). The fibroblast-derived 
matrix was produced as previously described (Beacham et al., 2006). To evaluate the 
quality of FN fibers produced by fibroblast, ECM were fixed with 3% paraformaldehyde 
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5.9.2 Matrigel invasion assay
For invasion assay, MDA-231 trasfected cells (10 x 105cells/100 μl) were seeded on
Matrigel (BD Transduction, San Jose, CA, USA)-coated transwells in DMEM/F12 me-
dium containing 0.1% BSA (Sigma-Aldrich). NIH-3T3-conditioned medium in the
lower chamber was used as chemoattractant. The conditioned medium from NIH-3T3
mouse fibroblasts contains a variety of growth factors that could act as chemoattractants 
for tumor cells (Shaw, 2005). After 5 h of incubation at 37°C non-invading cells were 
removed from the upper side with a cotton swab, and cells invadeding and crossing the 
membranes were fixed with 100% cold methanol and stained with 1% crystal violet (0,5% 
crystal violet in 20% methanol). Cells invading to the lower side were counted from 6 
representative 20x fields per condition, in at least 4 independent experiments, each per-
formed in duplicate or in triplicate.
5.9.3 Fluorescent-gelatin degradation assay
For gelatin degradation assay, MDA-231 cells trasfected for 24-48 h were replated for 5 h 
(5x104 cells) on Oregon-green 488-conjugated gelatin (Life Technologies) and 10 μg/ml 
FN pre-coated coverslips. Cells were then fixed with 3% PFA, stained with appropriate 
primary and secondary antibodies or fluorescent phalloidin, and observed with an Olym-
pus IX70 microscope (Olympus, Tokyo, Japan). ImageJ software was used to measure 
degradation (dark spots on fluorescent gelatin bright areas), projected
cell areas, and number of active invadopodia (cortactin-, filamentous actin-positive dots 
that localized with areas of gelatin degradation.) (Clark et al., 2007).
5.10 In vivo experiments
5.10.1 Experimental metastasis assay 
For experimental metastasis assay, cell lines stably expressing either GFP-Liprin-a1, GFP, 
shRNA1, shRNA2 or pSuperVectorGFP were seeded in 10 cm diameter plates and trypsi-
nized after reached the 70% of confluence. MDA-MB-231 WT cells were used as positive 
control. Cells were counted with Tripan Blue and aliquots of 500 000 cells each in 100 ml 
of PBS were prepared. Four-weeks-old athymic nu/nu female mice were obtained from 
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Harlan. Animal care was in accordance with the guidelines of Italian Ethic Committee. 
Mice were injected in the left lateral tail vein. Eight-ten mice per experimental conditions 
were used. 5 weeks after the injection, mice were euthanized and lungs were washed 
twice by the injection of PBS into the thrachea and then explanted. Left lungs were fixed 
in 4% PFA for 2 hours, cryoprotected with sucrose in PBS (10-20 and 30%), embedded 
Tissue Tek® O.C.T.™ compound (Miles) and snap frozen by liquid nitrogen. In general, 
5 -10 mice were used for each experimental condition.
5.10.2 Spontaneous metastasis assay
For spontaneous metastasis assay, cell lines stably expressing either GFP-Liprin-a1, GFP, 
shRNA1, shRNA2 or pSuperVectorGFP, were seeded in 10 cm diameter plates and trypsi-
nized after reached the 70% of confluence. MDA-MB-231 WT cells were used as positive 
control. Cells were counted with Tripan Blue and aliquots of 4*106 cells each in 50 ml of 
PBS were prepared. NOD scid gamma (NSG) mice were obtained from TIGET colony at 
san Raffele Scientific Institute. NSG mice harbor mutation in Prkdc gene (DNA activated 
polypeptide gene) that causes lack of T- or B cells but still have high NK activity; SCID 
mutation into the NOD background resulting in decreased activity of NK cells, defects 
in immune system, deficienccy in C5 and inability of macrophage to produce IL-1β in 
response to stimulation with LPS; and deletion of IL2 rγ, required for IL-2, IL-4, IL-7, 
IL-9, IL-15 and IL-21 signaling. Animal care was in accordance with the guidelines of 
Italian Ethic Committee. For mammary fat pad (MFP) tumor cell transplantation, mice 
were anesthetized with Avertin, (15mg/kg, Sigma-Aldrich) the right III MFP of 9-week–
old NSG female mice was visualized through a small skin incision, and 2x10
6 
tumor cells 
were injected in 50 μl of PBS with visual confirmation of MFP engorgement. The incision 




tissue adhesive (Alcyon, Italy). After transplantation, 
palpable tumors developed in 8-10 days and then the tumor size was determined every 
3-4 days by caliper measurements. Tumor volume was calculated by a rational ellipse 
formula (m1 x m1 x m2 x 0.5236, where m1 is the shorter axis and m2 is the longer axis). 
In general, 4-10 mice were used for each experimental condition. 
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5.11 Histological analysis
5.11.1	 Immunofluorescence	of	cryosection
From spontaneous metastasis assays, primary tumors were collected, fixed 2 hours in 
4% PFA, cryoprotected with sucrose in PBS (10-20 and 30%), then embedded in Tissue 
Tek® O.C.T.™ compound (Miles) and snap frozen by liquid nitrogen. Twelve-mm frozen 
sections were taken by cryostat. For immunofluorescence, primary antibodies were re-
vealed by incubation for 1.5–2 h with Alexa Fluor-conjugated secondary antibodies and 
4′ ,6-Diamidino-2 Phenylindole (DAPI, Sigma-Aldrich) for nuclear staining. Confocal 
analysis was performed with a Leica TCS SP2 (Leica Microsystems).
5.11.2	 Quantification	of	metastatic	area
To quantify metastasis in experimental metastasis assay, I euthanized mice 5 weeks after 
injection. To quantify metastasis in spontaneous metastasis assay I euthanized mice 38 
day after transplantation. In both cases left lungs were collected, fixed in 4% PFA for 2 
hours and cryoprotected with sucrose in PBS (10-20 and 30%), then embedded in Tissue 
Tek® O.C.T.™ compound (Miles) and snap frozen by liquid nitrogen.  Sexteen-mm frozen 
sections were taken at 160- mm intervals to obtain full coverage of the organ. Sections 
were then stained with H&E for histological examination. I photographed each lung 
section and quantified the relative metastatic area. To do this, the ratio between the meta-
static area and the total section area was measured using ImageJ software by performing 
a threshold to create a binary image in which the total red area corresponding to the area 
covered by metastases. ImageJ software was used also to measure the area of the  entire 
lung section. The ratio between metastatic area and total section area was measured and 
indicated as relative metastatic area per section. The average of all the metastatic areas 
per section of an entire lung was calculated.
5.11.3 Hematoxillin&Eosin staining
For H&E staining Hematoxillin solution and Eosin solution 2% were purchased from Sig-
ma (Sigma Aldrich). Sections were stained for 30 seconds with Hematoxillin solution, 
washed three or four times in distilled water then stained with Eosin solution for 2 minutes 
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and washed in distilled water again. Sections were dehydrated in 50-70-90-100% ethylic 
alchool and then in xylene. Sections were mounted in DPX mounting medium (Sigma 
Aldrich) and let dry o/n at room temperature before the analysis.
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